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Abstract 
Title 
³A study to assess the effectiveness of honey on constipation among 
antenatal mothers in third trimester admitted   in Institute of Obstetrics and 
*\QDHFRORJ\DQG*RYWKRVSLWDOIRUZRPHQDQGFKLOGUHQ&KHQQDL´ 
Constipation is a common minor disorder of pregnancy. The approach to 
constipation in pregnancy is similar to that used for the general population, with 
special attention to safety of medications.  
Need for study 
 Pregnancy is one of the most exciting and important events in each 
woman's life. During this period the pregnant women may have some minor 
disorders; among that constipation is a more common troublesome one. The 
investigator aimed to bring a cost effective home remedy for the discomfort 
experienced by the antenatal mothers.  
Objectives 
x To assess the level of constipation among antenatal mothers in third trimester 
in both control and experimental group. 
x To compare the level of constipation among antenatal mothers in third 
trimester in pre test and post-test among experimental and control groups. 
x To evaluate the effectiveness of honey on constipation among antenatal 
mothers in third trimester in experimental group. 
x To find the association of level of constipation with selected demographic 
variables among the antenatal mothers in third trimester. 
 
Research Methodology 
x Research approach:  Quantitative approach 
x Study setting:  Antenatal wards of Institute Of Obstetrics and Gynaecology,  
x  Study design : Quasi experimental study design 
x Study population:  Antenatal mothers in third trimester with constipation 
admitted in antenatal wards in IOG. 
x Sample size:  Comprised of 60 antenatal mothers in third trimester in which 30 
sample in each control and experimental groups. 
x Sampling technique: Purposive sampling technique 
x Data collection procedure:  For experimental group 10 ml of honey in 100 ml 
of warm water was administered twice a day for 3 consecutive days for the 
subjects having constipation and for the control group routine care was given. 
 
Data analysis: The data were analyzed by descriptive statistical methods like 
mean, standard deviation, frequency percentage and inferential statistical 
methods like independent t-test, chi square and t-test.  
 
Study results: The comparison between pre-test and post-test among 
experimental group, t=6.75 and it was statistically significant with p 
value=0.001. Mean difference between pre-test and post-test among 
experimental group; 22.5% (95% CI 20.5%±24.5%). shows the effectiveness of 
honey on constipation among antenatal mothers in third trimester. 
 
Discussion: In post-test constipation score reduced 22.5% with p value=0.001 
in experimental group and 5.8% reduced with p value=0.53  in control group. 
There is statistically significant difference in level of constipation among 
experimental and control group.  
 
Conclusion: Honey administration for constipation is easy to implement, safe 
for pregnant women, non-invasive, and low-cost. The excavated results 
supported the incorporation of complementary medicine to relieve constipation 
among antenatal mothers. 
 
 Key words: Pregnancy, Constipation, Honey, Effectiveness 
TABLE OF CONTENTS 
Chapter TITLE Page No 
I INTRODUCTION 
1.1 Need for the study 
1.2 Statement of the Problem 
1.3 Objectives 
1.4 Operational definition 
1.5 Assumption 
1.6 Hypothesis 
1.7 Delimitation 
1 
5 
7 
7 
8 
8 
8 
9 
II REVIEW OF LITERATURE 
2.1      Review of related literature 
2.2      Conceptual frame work 
 
10 
22 
III 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESEARCH METHODOLOGY 
3.1      Research approach 
3.2      Duration of the study  
3.3      Study  setting 
3.4      Study design 
3.5      Study population 
3.6      Sample size 
3.7      Sample selection criteria 
3.7.1   Inclusion criteria 
3.7.2   Exclusion criteria 
3.8      Sampling technique 
3. 9     Research variables 
3.10    Development and description of tool 
3.10.1 Development of tool 
3.10.2 Testing of the  tool 
3.10.3 Content Validity 
3.11     Ethical consideration  
3.12     Pilot study 
3.13     Reliability 
3.14     Data collection procedure 
3.15     Data entry and  analysis 
27 
27 
27 
27 
28 
28 
28 
28 
28 
29 
29 
28 
29 
29 
31 
31 
31 
31 
32 
32 
33 
Chapter TITLE Page No 
IV DATA ANALYSIS AND INTERPRETATION 35 
V SUMMARY OF THE RESULTS 60 
VI 
VII 
DISCUSSION 
SUMMARY& RECOMMENDATION  
7.1     Implication of the study 
7.2     Limitations 
7.3     Recommendation for further studies 
64 
68 
68 
69 
70 
 
 
 REFERENCES a-j 
 APPENDICES i-xxvi 
 
LIST OF TABLES 
Table 
No TITLE 
Page 
No 
4.1 Distribution of demographic  profiles 37 
4.2 Distribution of  obstetric variables 39 
4.3 Distribution of  personal variables  40 
4.4 Pre-test level of constipation in relation to signs and symptoms  42 
4.5 Pre-test level of constipation in relation to score 44 
4.6 Post- test level of constipation in relation signs and symptoms 45 
4.7 Post-test level of constipation in relation to score  47 
4.8 Comparison of pretest and post test in experimental group  48 
4.9 Comparison of pretest and post test in control group  49 
4.10 Comparison of experimental and control group  50 
4.11 Comparison of pretest and post test  51 
4.12 Effectiveness of honey in reduction of signs and symptoms  52 
4.13 Effectiveness of honey in reduction of constipation between experimental and control group  53 
 
4.14 
Association between level of constipation reduction and 
demographic variables in experimental group  54 
4.15 Association between level of constipation reduction and obstetric 
variable among experimental group  55 
4.16 Association between level of constipation reduction in personal 
variable among experimental group 56 
4.17 Association between level of constipation reduction and 
demographic variables in control group 57 
4.18 Association between level of constipation reduction and obstetric 
variables in control group 58 
4.19 Association between level of constipation reduction and personal 
variables in control group 59 
LIST OF FIGURES 
Figure 
No TITLE  
2.1 Conceptual frame Work ± theory  
3.2 Schematic representation of  Research Design  
4.1 Age wise distribution of antenatal mothers  
4.2 
Educational status wise distribution of antenatal 
mothers 
 
4.3 Occupational status wise distribution of antenatal mothers 
 
4.4 Family monthly income wise distribution of antenatal mothers 
 
4.5 Religion wise distribution of antenatal mothers   
4.6 Residence wise distribution of antenatal mothers  
4.7 Type f family wise distribution of antenatal mothers  
4.8 Gravida wise distribution of antenatal mothers  
4.9 Gestational week wise distribution of antenatal mothers 
 
4.10  Distribution of consumption of iron tablets among antenatal mothers 
 
4.11 Bowel habits wise distribution of antenatal mothers  
4.12 Fluid intake wise distribution of antenatal mothers  
4.13 Diet pattern wise distribution of antenatal mothers  
4.14 Daily activities wise distribution of antenatal mothers 
 
4.15 Relief measures wise distribution of antenatal mothers 
 
Figure 
No TITLE  
4.16 
 
Pre-test level of constipation in relation to signs and 
symptoms  
 
4.17 Pre-test level of constipation in relation to score 
 
4.18 Post-test level of constipation in relation to signs and symptoms 
 
4.19 Post- test level of constipation in relation to score 
 
4.20 Comparison of pre-test and post- Box plot 
 
4.21 Effectiveness of honey on constipation 
 
4.22 Association between level of constipation reduction DQGPRWKHUV¶DJH 
 
4.23 Association between level of  constipation reduction and educational status 
 
4.24 Association between level of constipation reduction and type of family 
 
4.25 Association between level of constipation reduction and daily activities 
 
4.26 Association between level of constipation reduction and bowel pattern 
 
LIST OF APPENDICES 
 
S.NO PARTICULARS  PAGE 
NO 
APPENDIX-I Permission letter from Institutional Ethics 
Committee 
 i 
APPENDIX-II Certificate of Content Validity ii-iii 
APPENDIX-III Permission letter from the director, IOG iv 
APPENDIX-IV Tool for data collection v-xii 
APPENDIX-V Research Consent form xiii-xiv 
APPENDIX-VI Coding sheet xv-xxv 
APPENDIX-VII English Editing Certificate xxiv 
 
 
 
 
 
 
1 
 
CHAPTER -I 
INTRODUCTION 
´7KHPRVWDPELWLRXVGUHDPRIDZRPDQLQKHUOLIHLVJLYLQJELUWK 
                       Motherhood is... difficult   and... Rewarding." 
                                                                                                               ² Gloria Estafan 
               Every pregnancy is unique experience for the women and each 
pregnancy that the women experience will be new and different. Pregnancy 
care is one of the wonderful and noble services imposed by nature. The 
objective of obstetrics is that every pregnancy should culminate in healthy baby 
and healthy mother. The most ambitious dream of a woman in her life is giving 
birth1.  
             During pregnancy there is progressive anatomical, physiological and 
biochemical changes in all systems of the body. These physiological changes 
are the normal adaptation to accommodate as well as to promote the growth of 
embryo or fetus2. Hormones play an important role in changing maternal 
physiology during pregnancy largely orchestrated by the endocrine system 
through the hormones; these changes arise in response to maternal adaptation 
to the increasing demands of the growing fetus. Anatomical and physiologic 
changes also take place in each organ of the gastrointestinal system.3  
             During pregnancy the motility in the gastrointestinal tract is decreased, 
resulting in a prolonged gastric emptying time and a longer intestinal transit 
time. A generalized relaxation of the smooth musculature of the gastro 
intestinal tract occurs under the influence of progesterone. Pregnancy and the 
postpartum period are often associated with many gastrointestinal complaints, 
including nausea, vomiting, and heartburn; however, the most troublesome 
complaints in some women are defecatory disorders such as constipation and 
faecal incontinence. These disorders are often multi factorial in etiology, and 
many studies have looked to see what risk factors lead to these complications4.  
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Constipation is a common minor disorder of pregnancy where a woman 
has difficulty in passing dry stool or unusually dried stool, irregular and 
infrequent or difficult evacuation of the bowels5. Constipation during 
pregnancy can also cause haemorrhoids, permanent impairment as there is 
evidence that straining to defecate can damage the pudendal nerve and impair 
the supportive function of the pelvic floor musculature while it is also an 
important factor in the development of uterovaginal prolapse6. 
                       The approach to constipation in pregnancy is similar to that used 
for the general population, with special attention to safety of medications. 
Current recommendations include dietary manipulations to increase the 
consumption of fibre. It is also recommended to increase fluid intake and 
include a moderate amount of daily exercise7. If these are ineffective, laxatives 
are the second line of therapy, stimulant laxatives were more effective (Peto 
Odds Ratio 0.30; 95% CI 0.14±0.61), although stimulants were associated with 
significantly more abdominal pain and diarrhoea8. 
 Almost many of pregnant women get constipated at some point. 
Progesterone and somatostatin may also inhibit the release of motilin, a peptide 
hormone that normally inhibits smooth muscle. Moreover, relaxin, a 
polypeptide that inhibits myometrial contraction during pregnancy, also 
appears to inhibit the smooth muscle of the gastrointestinal tract. This means 
that food passes through the intestines more slowly. The problem may be 
compounded later in pregnancy by the pressure of growing uterus on the 
rectum9. 
   According to American Pregnancy Association approximately 6 million 
pregnancies occurs every year throughout the United States. According to 
National Health Interview Survey reports about 4.4 million pregnant women 
complains of constipation10. According to Cullen et al. (2007), several studies 
have demonstrated that the increase of colonic water absorption during 
pregnancy could lead to the formation of small and hard stools, according to 
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total colonic perfusion studies, aldosterone increases water absorption in 
pregnant women11.  
        Iron supplements, particularly in high doses, can make constipation 
worse. Other important causes for constipation during pregnancy include 
dietary factors, such as lack of dietary fiber, particularly non-starch 
polysaccharide (NSP) and water. Fiber binds water but this property is lost 
when it is split by colonic bacteria. Certain types of fiber (e.g. bran) are poorly 
splitted by bacteria and so retain their ability to bind water. Dietary fiber 
increases stools bulk, weight and frequency, and reduces the mean transit 
time12.  
Light physical activity appears to promote regular bowel movements 
during pregnancy; therefore a sedentary lifestyle may likewise cause or 
exacerbate constipation13. Treatment typically consists of dietary measures, 
such as increasing   fiber and fluid intake, behavioural changes, such as 
physical activity, and the use of probiotics or laxatives12.  
A systemic review conducted by Bradley et al. (2007) in Springer, 
Cochrane explained the importance of probiotics in treating constipation 
among pregnancy14. Milliano et al. (2012) probiotics that alter the colonic flora 
can also improve bowel function. Also in several studies, probiotics have 
shown to be safe for both mother and fetus during pregnancy15 
Honey is the substance which has probiotics to treat constipation and 
honey is widely used to treat constipation. Honey has had a valued place in 
traditional medicine for centuries16. Honey has always been a very popular 
culinary delicacy as well as an important medical remedy for many millennia. 
Across the globe, our ancestors seemed to be well aware of the many health 
benefits of honey. In India, honey is an important  part of Siddha and Ayurveda 
the ancient, traditional systems of medicine. Several other cultures have also 
used honey for various medical purposes. Today, honey is the focus of much 
scientific research by the medical community17.      
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Few complementary therapies supplement the probiotics which is used 
to treat constipation. Honey is a natural laxative due to its moisturizing 
properties. It can be taken daily to prevent as well as to treat constipation. 
Honey is highly nutritious, it has traces of minerals, vitamins and antioxidants 
which destroy free radicals and delay ageing. In short, it is a safe and 
wholesome food for old, children and adults. Honey is a plant by-product and 
used medicinally around the world. Honey is also an energizer, helping 
workers and athletes overcome fatigue and retain energy18.       
1.1 Need for the study   
              Pregnancy is one of the most exciting and important events in each 
woman's life involving many factors that should be considered in advance such 
as changes in diet habits and lifestyle that may be worked out.  
                  While constipation is a common complaint among the general 
population, some patients with no history of bowel problems develop 
constipation for the first time during pregnancy while others already suffering 
constipation prior to their pregnancies will often find their symptoms worsen 
while pregnant11. Although a definitive cause for this disturbing complaint 
remains unknown, the causes of constipation during pregnancy are likely to be 
multi factorial as hormonal changes and mechanical changes play an important 
role, as well as dietary factors and lifestyle issues.   
Bradley, Catherine S.MD, MSCE et al. (2007) conducted a study in 
North America to prospectively estimate constipation prevalence and risk 
factors in pregnancy. They enrolled healthy pregnant women in this 
longitudinal study during the first trimester. Constipation prevalence rates were 
24%, 26%, 16% and 24% in the first, second, and third trimesters and 3 months 
postpartum, respectively14.  
                   
Vazquez J. (2010) conducted a study on constipation, haemorrhoids, and 
heartburn in pregnancy in Los Angeles19. They reported constipation in 
pregnant women varies between 11% and 38%. 
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The Indian Society of Gastroenterology Task Force 53% of pregnant 
women are suffering from constipation 77% suffering from incomplete 
evacuation and 46% suffer from straining at stools 20. 
 The Hippocratic principle of doing no harm to the patient is particularly 
relevant to the selection of therapeutic agents, as most have untoward side 
effects. Honey has been linked with digestive health since ancient times. Early 
civilisations such as the Romans and Arabic empires used honey as part of their 
treatments for gastro intestinal disorder21. This proposed protocol is easy to 
implement, safe, non-invasive, and low-cost. 
Man has always been ignorant of the plethora of natural products that 
are available around him. In his search for newer treatment modalities in 
medicine, he has reached back to the source of several vital materials that are 
available in nature. These natural products are not only highly bioactive, they 
also have several interactions that are synergistic in preventing infections, 
promoting healing and preserving health in total 22. 
                   ´/HWIRRGEHWK\PHGLFLQHDQGPHGLFLQHEHWK\IRRGµ 
                                                                                                   -HIPPOCRATES  
       Honey is one such substance that exemplifies this statement. 
&RQVLGHUHG QDWXUH¶V HQHUJ\ERRVWHU KRQH\ LV D QDWXUDO UHPHG\ WKDW KDV EHHQ 
used for centuries. A rich source of natural sugars, honey also contains a host 
of vitamins, minerals, and   antioxidants18.   
       The substance is effective in treating variety of conditions. Used as a 
medical treatment and preventive, honey is considered the simplest most 
effective option available. Honey can effectively prevent Pregnancy Induced 
Hypertension, anaemia in pregnancy, pregnancy combined with hepatitis and 
other diseases23.  
 Honey helps in production of intestinal mucus, hydrates the colon and 
infuses water into dried stool. This helps to pass motion easily. Honey has 
Probiotics that alter the colonic flora and also can improve bowel function.  
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Pregnant women will appear the phenomenon of constipation during 
pregnancy, and honey has Runchang laxative effect, so eating honey can 
effectively prevent constipation and haemorrhoids bleeding24. 
               Many people find a hot drink in the morning stimulates the bowels. 
Lemon and honey in hot water seems to stimulate mucus production in the 
intestine, aiding in flushing of toxins25.  
Selection of honey is important. Mr.Azhim Sanyal (2016), Heads of 
consumer voice puts it, in The Times of India, Dabur honey ranked No: 1 in 
purity. Dabur honey is the purest, in terms of meeting not only the FSSAI 
standards and met the EU standards as well26.  
In view of the above studies and from the investigator experience in 
caring for the antenatal mothers it was observed that constipation was one of 
the discomfort experienced by the antenatal mothers. The researcher is 
interested in incorporating complementary therapies in rendering nursing care 
DQGDOVRUHVHDUFKHU¶VFXULRVLW\LQH[SHULPHQWDOVWXdy for helping the clients to 
relieve constipation by non pharmacological measures.  To be specific the 
researcher is intended to find out the effectiveness of honey to relieve 
constipation among antenatal mothers in third trimester. There by aiming to 
bring with a cost effective home remedy for the discomfort experienced by the 
antenatal mothers. 
 
1.2 Statement of the problem 
³A study to assess the effectiveness of honey on constipation among antenatal 
mothers in third trimester admitted   in Institute of Obstetrics and Gynaecology 
DQG*RYWKRVSLWDOIRUZRPHQDQGFKLOGUHQ&KHQQDL´ 
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1.3 Objectives  
x To assess the level of constipation among antenatal mothers in third 
trimester in both control and experimental group. 
x To compare the level of constipation among antenatal mothers in third 
trimester in pre test and post-test among experimental and control 
groups. 
x To evaluate the effectiveness of honey on constipation among antenatal 
mothers in third trimester in experimental group. 
x To find the association of level of constipation with selected 
demographic variables among the antenatal mothers in third trimester. 
1.4 Operational definitions:  
1. Effectiveness: is the improved level of elimination pattern among 
antenatal mothers with constipation by comparing pre-test and post-test.  
2. Constipation:  is a condition in which there is difficulty in emptying the 
bowels, associated with less frequent bowel movements and / or hardened 
faeces and / or rectal fullness or pressure and/ or small volume of stool5. 
3.  Antenatal mother:  refers to all the pregnant women both primi and 
multi gravida before child birth. 
4. Third trimester:  refers to a period beyond 27 weeks of gestation.  
5. Honey : is sold in  shops in the trade name of  Dabur,10 ml two times a 
day in 100 ml of warm water will be given.  
1.5 Assumptions:  
x Women during pregnancy will experience constipation in certain level. 
x Honey regulates the normal bowel elimination pattern. 
x  Honey may relieve constipation during third trimester pregnancy in 
certain level.   
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1.6 Research hypotheses:  
      H1: There may be significant difference in level of constipation 
among experimental and control group. 
     H2:  There may be significant association between the level of 
constipation and the selected demographic variables.  
1.7 Delimitation 
                 The study is limited to four weeks.  
                 The study is done among antenatal mothers in third trimester with 
constipation admitted in antenatal wards in Institute of Obstetrics and 
Gynaecology and Govt hospital for women and children, Chennai. 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
CHAPTER II 
 
REVIEW OF LITERATURE 
           
               Any scientific investigation starts with a review of the literature. In 
fact, working with the literature in an essential part of the research process 
which generates the idea, helps in developing significant questions are regarded 
as instrumental in the process of research design. Reviews are short articles that 
give brief information regarding the work done in a particular area over a 
period of time.  
 
             This chapter deals with the selected studies, which are related to 
objectives of the proposed study. 
 
2.1 Review of related literature 
2.2 Conceptual framework 
 
2.1 Review of related literature 
2.1.1: Studies related to constipation 
2.1.2: Studies related constipation in pregnancy  
2.1.3: Studies related to honey on treatment of constipation  
2.1.4: Studies related to honey and its effects other than constipation  
 
2.1.1: Studies related to constipation 
Dik VK, Siersema PD, Joseph A, et al. (2014) conducted a study to  
investigate chronic constipation-related direct medical costs in patients with 
newly diagnosed chronic constipation and  study differences in costs according 
WR QDWXUDO KLVWRU\ 7KH\ LGHQWLILHG ௗ SDWLHQWV QHZO\ GLDJQRVHG ZLth 
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chronic constipation in a Dutch health insurance database. Individuals with 
chronic constipation were selected on the basis of chronic laxative use and 
diagnostic related groups for chronic constipation. Costs were highest in 
patients with persistent disease, compared with patients with episodic and non 
recurrent disease 27 (P<0.01).  
Yiannakou Y, Piessevaux H, BouchouchaM, et al. (2014) conducted a 
study in Chicago on chronic constipation. This was a multicenter, stratified, 
randomized, parallel-group, double-blind, placebo-controlled, phase 3 study. In 
total, 374 patients were enrolled in the study. Significantly more patients 
achieved a mean of three or more per week in the prucalopride (laxative) group 
(37.9%) than in the placebo group (17.7%, P<0.0001). The proportion of 
patients rating their constipation treatment as "quite a bit" to "extremely" 
effective at the final on-treatment visit was 46.7 and 30.4% in the prucalopride 
and placebo groups, respectively. The difference between treatment groups was 
statistically significant  28(P<0.0001).  
Layer P, Stanghellini V. (2014) conducted a study in Adelaide on 
Irritable bowel syndrome with constipation (IBS-C) represents a significant 
burden to patients and healthcare systems due to its prevalence and lack of 
successful symptomatic resolution with established treatment options. 
/LQDFORWLGH ȝJ KDV UHFHQWO\ EHHQ DSSURYHG E\ WKH (XURSHDQ 0HGLFLQHV
Agency (EMA) for moderate-to-severe IBS-C and by the US Food and Drug 
Administration for IBS-& ȝJ GRVH DQG IRU FKURQLF FRQVWLSDWLRQ ȝJ
dose). Clinical trial data demonstrate that linaclotide (60%) improves 
abdominal symptoms (pain, bloating) and bowel symptoms (constipation) 
compared with placebo in patients with IBS-C. The difference between 
treatment groups was statistically significant 29 (P<0.0001).  
Chevalier P, Lamotte M, Joseph A, et al. (2013) conducted a study on 
chronic constipation. The objectives of this study were to assess hospitalization 
resource use and costs associated with chronic constipation and its 
complications in Belgium. This was a single country, retrospective study which 
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comprises data on 34% of acute hospital beds in Belgium and contains 
information on patient demographics, length of stay (LOS), billed costs, drug 
use, diagnoses, and procedures.. In total, 1541 eligible patients were identified. 
The average unadjusted cost per day in hospital for idiopathic constipation was 
¼ 7KH PRVW IUHTXHQW GUXJ DQG SURFHGXUDO WUHDWPHQWV ZHUH ZLWK
complications: 42.61%; without complications: 35.69%), and transanal enema 
(2.32% and 2.03%), respectively 30. 
2.1.2: Studies related to constipation in pregnancy 
Derbyshire31 et al. (2014) conducted two prospective cohort studies in 
Alaska were found with moderate study quality, using small population 
samples, through self-administered questionnaires and diaries. They used Rome 
II criteria to define constipation. Data was collected exclusively at each 
trimester and 6 weeks post-partum from primiparous pregnant women. From 
the 94 subjects that were initially recruited only 42 successfully completed 
every study stage, an overall compliance rate of 42%. The study estimates that 
the prevalence of constipation within the sample population was greatest in the 
first and second trimesters, 35% and 39% respectively and in the third 
trimester, 21% and at 6 six weeks postpartum, 17% .The mean prevalence rate 
of constipation during pregnancy of this study was 32%. 
Bradley et al. (2013) conducted a study in Portland; data were collected 
at each trimester and 3 month postpartum. The follow-up data were returned by 
63 women (61.2%) at 3months postpartum. Of the103 women who initially 
returned the data in the first trimester. This study estimates that constipation 
prevalence rates were 24% in the first trimester , 26% in the second, 16% in the 
third, and 24% and 3 months postpartum. Overall, 51 % women reported 
constipation at some point during pregnancy. This study states that functional 
constipation, defined using the Rome II criteria, occurred in 16±26% of women 
studied in each pregnancy trimester14.   
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Jewell DJ, Young G (2010) Cochrane Library conducted a study on 
urinary in continence and constipation during pregnancy. A total of 2,062 
women (858 primi gravidae, 1,057 multi gravidae and 147 multi gravidae 
participated. A questionnaire was administered on the maternity wards, Dublin. 
Of the total number of women questioned initially, 59% experienced some 
degree of leaking the incidence of which significantly increased with 
parity(x2=56.26; P=0.0001). The incidence of incontinence 31% in the multi 
parous and 11% in precipitous group of the total women questioned, 355 
suffered from constipation, the incidence of which also significantly increased 
in parity32(x2=6.034, P=0.049). 
Ponce, Julio, Martínez, Beatriz et al. (2008) conducted a study in 
Auckland on constipation during pregnancy. An increase in the prevalence of 
constipation during pregnancy has been suggested to occur. They designed a 
prospective study to evaluate the prevalence of constipation during pregnancy 
and puerperium, to investigate possible associations with eating habits and 
lifestyle, and to evaluate the frequency of laxative use. The questionnaire was 
administered in the obstetric clinic in the first trimester of pregnancy, and by 
telephone in the second and third trimesters, and in the puerperal period. The 
prevalence of self-reported constipation in these time periods was 45.4, 37.1, 
39.4, and 41.8%, respectively33. 
Kathleen Marshall, Kate A. Thompson. (2007) International Journal of 
Obstetrics & Gynaecology (2005), to assess the impact of pregnancy upon 
incontinence and constipation. A questionnaire survey conducted at Maternity 
wards in the Rotunda Lying in Hospital, Dublin, and Republic of Ireland.7771 
women who were delivered of live born infants Questionnaires were delivered 
and collected by physiotherapy staff as part of routine postnatal care. Analysis 
RI GDWD XVLQJ Ȥ2 tests showed significant differences between three parity 
groups for symptoms of both urinary incontinence (Ȥ2= 119.54, df = 2, P = 
0.000) and constipation (Ȥ2= 12.53, df = 3, P = 0.002); the incidence of both 
constipation and urinary incontinence increased with parity34.  
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Emma Derbyshire, Jill Davies Vassiliki costarelli et al. (2006) few 
studies in Sweden appear to have investigated the prevalence of constipation 
for all three trimesters of the gestational period, or indeed after birth. Using a 
prospective 4- to 7-day weighed food diary, International Physical Activity 
Questionnaire and 7-day bowel habit diary, dietary factors, physical activity 
levels and bowel habit parameters were assessed and examined concurrently at 
weeks 13, 25, 35 of pregnancy and 6 weeks post-partum. Ninety-four 
primiparous pregnant women were initially recruited, and 72, 59, 62 and 55 
completed the first, second, third trimester and post-partum study stages, 
respectively. This study demonstrates that dietary factors may play a role in 
terms of preventing, or alleviating, bowel habit perturbations both throughout 
and after pregnancy31. 
 H. Jorien van Brummen, Hein W. Bruinse, Geerte van de Pol et al. 
(2005) A prospective cohort study was undertaken in Netherland  to evaluate 
the impact of pregnancy and the first delivery on the defecatory symptoms and 
to identify associated factors among 487 nulliparous pregnant women who 
completed four questionnaires. Flatus and fecal incontinence, constipation, and 
painful defecation are already present in early pregnancy and are significantly 
predictive for reporting symptoms after delivery, except for fecal incontinence. 
A third or fourth degree sphincter tear was significantly associated with fecal 
incontinence and constipation35. 
Annie S. Anderson. (2005) conducted a study a comparative study in 
Melbourne to evaluate dietary factors in the aetiology and treatment of 
constipation during pregnancy. Using a 7-day weighed-intake method, dietary 
factors implicated in the aetiology of constipation were examined by 
comparison between the nutrient intakes of 9 women with constipation in the 
third trimester of pregnancy who had not altered their diets, and a matched 
group of 9 women who had not suffered constipation at any time during 
pregnancy. The nutrient intakes of 40 women with constipation in the third 
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trimester of pregnancy were examined to assess dietary changes made in 
attempts to treat constipation. No difference in intakes of dietary fibre was 
found between those who claimed to have increased their intakes, and those 
who had not altered their diets. Both were well below the level of dietary fibre 
intake known to be successful in treating constipation36.  
Neri I, Blasi I, Castro P, Grandinetti G .et al. (2004) conducted an 
observational open-label study in Brasilia  for constipation during pregnancy 
state that prevalence of constipation (11-38%), which focused solely on bowel 
movement frequency while their study demonstrates that other symptoms of 
straining, lumpy or hard stools, and sensation of incomplete evacuation were 
more commonly reported than infrequent defections. This study also estimates 
that women who reported a history of constipation (41.7%, P=0.04) were more 
likely to develop constipation during pregnancy37. 
Levy N, LembergE, Sharf M et al. (2002) from the Medical Department 
µ$¶ DQG Gastrointestinal Clinic and the Department of Gynaecology and 
Obstetrics. The Rothschild Municipal-Government Hospital, Haifa. One 
thousand healthy postpartum Israeli women were interviewed on their bowel 
habit before and during pregnancy. In 54.6% there was no change in the bowel 
frequency during pregnancy, while 34.4% had an increased and 11% a 
decreased frequency. When the series was analysed according to the ethnic 
backgrounds, it was found that the Arab women tended to be even less 
constipated than the Jewish ethnic groups. Contrary to the generally accepted 
view that constipation is frequent in pregnancy, 79% of the women experienced 
either no change or an increase of bowel frequency during pregnancy, whereas 
constipation requiring laxative treatment was rare.38(8.5%) 
Magan Trottier, MSc, Aida Erebara, MD, and Pina Bozzo et al. (2001) 
conducted an experimental study in Mexico city on treating constipation in 
pregnancy. It has been estimated that approximately 11% to 38% of pregnant 
women experience constipation, which is generally described as infrequent 
bowel movements or difficult evacuation. Although the recommended first-line 
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therapy for constipation includes increasing fibre, fluids, and exercise, these are 
sometimes ineffective. It is recommended that osmotic and stimulant laxatives 
be used only in the short term or occasionally to avoid dehydration or 
electrolyte imbalances in pregnant women. Probiotics that alter the colonic 
flora might also improve bowel function4. 
David Jewell, Gavin Young. (2001) Cochrane Pregnancy and Childbirth 
Group conducted a study to assess the effects of different methods for treating 
constipation in pregnancy. Two suitable trials were identified. Fibre 
supplements increased the frequency of defecation (odds ratio 0.18, 95% 
confidence interval 0.05 to 0.67), and lead to softer stools. Stimulant laxatives 
are more effective than bulk-forming laxatives (odds ratio 0.30, 95% 
confidence interval 0.14 to 0.61), but may cause more side effects. Dietary 
supplements of fibre in the form of bran or wheat fibre are likely to help 
women experiencing constipation in pregnancy. If the problem fails to resolve, 
stimulant laxatives are likely to prove more effective32. 
2.1.3: Studies related to honey on treatment of constipation  
Huang Ali Jing Et al. (2012) conducted an experimental study to 
determine the impact of (honey 10 ml) twice a day for constipation among 
patients with KDHPRUUKDJLF VWURNH LQ /RQJKXD EUDQFK RI SHRSOH¶V KRVSLWDO
China.  A sample of 62 patients were randomly divided into control and 
experimental group, there were 31 cases in each group. Control group were 
given conventional stroke care, experimental group were given honey 
administration, addition to routine care. The incidence of constipation and 
degree of constipation of two groups were compared. The incidence of 
constipation in the experimental group was 25%, in control group was 61.29%. 
The study concluded that administration of honey is effective in management 
of constipation38. 
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Erejuva et al. (2012) conducted a quasi experimental study to assess the 
efficacy of honey with lemon juice in the treatment of constipation in China. 
Sample of 64 pregnant women with constipation was selected. The samples 
were divided into 35 experimental and 29 control groups. Intervention group 
received honey for four consecutive days, control group received health 
education regarding management of constipation. The incidence of constipation 
was lower in the intervention group than that in the control group (p<0.05). The 
study concluded that honey was effective in treating constipation39.  
Doreen mc clurg et al. (2011) conducted an experimental study with a 
view to administer the supplementation of honey for the alleviation of 
constipation symptoms in people with multiple sclerosis in Glasgow 
Caledonian University. A sample of 30 patients randomly divided into control 
and experimental group. Both group received fluid intake, fibre diet, and 
exercise. In addition experimental group was given 5-10ml of honey with warm 
water for 3 days. In both group constipation scale score decreased however the 
experimental group improved significantly more than the control group, 95% 
(t= 3.28, p.003).  They concluded that supplementation of honey is effective to 
alleviate constipation among geriatric patients40.  
Lars Lindholm et al. (2009) conducted a randomized controlled trail on 
the management of constipation in Sweden. A sample of 60 people with 
constipation was included and randomized in two groups. The intervention 
group only received honey mixture.  Symptoms assessed with gastro intestinal 
symptom rating scale according to total score (p= 0.003), constipation 
syndrome (p=.019). The intervention group also had significant increase of 
bowel movements compared to the control group (p=0.016). The study 
concluded that administration of honey for constipation regulates peristalsis 
and decrease the severity of symptoms of constipation41.  
Lamas et al. (2009) conducted a controlled clinical trial with a view to 
determine the use of honey. Clementon  management of constipation among 60 
elderly patients in the control group, Umea University, Sweden. Block 
randomization was used to allocate 60 volunteers with the mean age of sixty 
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four; the intervention group was given lemon with honey tea for 5 days. The 
control group continued with their routine care. The investigator used two 
validated questionnaires to evaluate the bowel function, Gastro Intestinal 
symptom Rating scale and the Bristol scale. The study concluded that this 
intervention significantly increase the number of bowel movements as well as 
it decreases the severity of constipation symptoms in the intervention group42. 
Jung HM et.al. (2004) conducted an experimental study to assess the 
effect of honey on constipation among 48 pregnant women, at Jiangsu medical 
university in China. The samples were randomly divided into two groups. 
Experimental of 25 and control group 23. Administration of honey tea twice a 
day to the experimental group and no honey was administered to the control 
group. The level of constipation was assessed by constipation assessment scale. 
There was a significant improvement in frequency of defecation and less 
severity of constipation in the experimental group compared to the control 
group. The result of the study concluded that the honey was effective to 
manage patients with constipation43. 
2.1.4: Studies related to honey and its effects other than constipation 
 
                 Bernadette Baca, Health Physicist. (2012) conducted an evaluatory 
study in Thailand among 124 anaemic rural populations. Iron deficiency 
anaemia is a condition that occurs when dietary intake or absorption of iron is 
insufficient, and the oxygen carrying capacity of the blood is compromised.  
Honey is mixed in tepid water and made to drink, once a day for a week.  It has 
beneficial impact on the red blood cell (RBC) count in the blood. RBCs are 
mainly responsible for carrying oxygen in the blood to various parts of the 
body. The honey-tepid water mixture raises the bloods haemoglobin levels, 
which takes care of anaemic conditions. They reduced the symptoms of fatigue, 
breathlessness, and depression and other problems44. 
Wang et al. (2012) conducted a prospective study in China. Cancers 
develop through mutation of the genetic structure of tissues. This mutation is 
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promoted by chemicals and other stimuli, some of which can be nutritionally 
based. It is generally accepted that heterocyclic amines and nitrosamines 
formed during roasting and frying of food can promote such activity. There is 
evidence that suggests that some compounds found in honey may slow or 
prevent such activity. They tested a number of different monofloral honeys and 
showed that they all had antimutagenic properties45. 
  Erejuwa, O. O., Sulaiman, S.A., Ab Wahab, M. S., et al. (2012) 
conducted an true experimental study in Jiangsu medical university in China 
among 17 patients on Digestive and Gut Health. Honey was given twice a day 
for gastric ulcer clients. There is research evidence, that honey inhibits growth 
of Helicobacter pylori, the bacteria associated with development of gastric 
ulcers. Recent work has highlighted the potential antibiotic effect of honey with 
a number of intestinal pathogens. It is believed that either component in honey 
stimulate sensory nerves in the stomach or the action is linked to an antioxidant 
effect. There has been health links associated with oligosaccharides present in 
honey with some evidence of prebiotic effects similar to fructo-
oligosaccharides more commonly used. This is a study which showed 
particular effects on the functionally important bacteria, bifido bacteria and 
lactobacilli 39. 
Tahereh Eteraf-Oskouei and Moslem Najafi. (2008) Clinical trials are 
conducted comparing honey dressing in burns with amniotic membrane 
dressing; silver sulfadiazine dressing and boiled potato peel dressing among 
100 burns clients. Honey dressing showed better improvement in these cases 
and showed early healing with lesser degree of contracture and scarring. Good 
histological preservation of skin grafts after honey treatment has also been 
described46.  
Pieper, Barbara. (2007) conducted a study on honey-based wound 
dressing in   Korea at Tongji laboratory. A honey product received US Federal 
Drug Administration approval in 2007, making this dressing an option for 
wound care. Honey has been found to exert anti-inflammatory and antibacterial 
20 
 
effects without antibiotic resistance, promote moist wound healing, and 
facilitate debridement. However, it may cause a stinging pain. This article 
provides a summary of the current evidence base for the use of honey and a 
review of its therapeutic effects and discusses implications for wound care in 
nursing practice47. 
Bansal V, Medhi B, Pandhi P. (2005) a study on honey as a remedy 
rediscovered and its therapeutic utility at Kathmandu University. Honey is used 
worldwide for the treatment of various ophthalmological conditions like 
blepharitis, keratitis, conjunctivitis, and corneal injuries, chemical and thermal 
burns to eyes. In experimental study, with topical application of honey as 
ointment, in 102 patients with non responsive eye disorders, improvement was 
seen in 85% patients and in remaining 15% there was no disease progression. 
Application of honey in infective conjunctivitis reduced redness, swelling, pus 
discharge and time to bacterial eradication48. 
Lynne M. Bang, Catherine Buntting, Peter Molan et al. (2003) 
conducted a study at Honey Research Unit, Waikato University, Hamilton, 
New Zealand. Honey is an effective antiseptic wound dressing, mainly the 
result of the antibacterial activity of hydrogen peroxide that is produced in 
honey by the enzyme glucose oxidase. The maximum levels of accumulated 
hydrogen peroxide occurred in honey solutions diluted to concentrations 
between 30% and 50% with at least 50% of the maximum levels occurring at 
15± 67% This is equivalent to a 10 cm3. 10 cm dressing containing 20 ml of 
honey becoming diluted with 10 to 113 ml of wound exudates. Maximum 
levels of hydrogen peroxide reached in the diluted honeys were in the range of 
1± 2 mol/L. Significant antibacterial activity can be maintained easily when 
using honey as a wound dressing, even on a heavily exuding wound49.  
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Al-Waili, N. S. (2003) a comparative study was conducted in Sun Yat-
Sen university among 43 clients with coronary heart disease; ingestion of a 
fructose/glucose mixture with consumption of honey on various heart and 
vascular biomarkers.  There is evidence to suggest that micro components in 
honey have a positive effect on markers of heart health. Other research has 
shown positive vascular effects in diabetic patients postulating that this could 
be used in the management of the condition. As in other areas the origin of the 
effect remains uncertain however one group has suggested that it could be due 
oligosaccharides present. A second has suggested that the effect is linked to 
stimulation of increased energy expenditure Nitric oxide (NO) metabolites can 
be present in honey. NO is a known marker of heart disease and elevated levels 
of metabolites may be evidence of a protective function50.  
Selwyn AP, Braunwald E51. (2001) an experimental study conducted in 
Thailand on effects of honey in ischemic heart diseases against cardiovascular 
risk factors such as hyperlipidemia and production of free radicals among 67 
middle age persons. Antioxidants present in honey include Vitamin C, 
monophenolics, flavonoids, and polyphenolics. Regular flavonoid intake is 
associated with a reduced risk of cardiovascular diseases. A wide range of 
phenolic compounds is present in honey which has promising effect in the 
treatment of cardiovascular diseases. In coronary heart disease (CHD), the 
protective effects of phenolic compounds include mainly antithrombotic, anti-
ischemic, anti-oxidant, and vasorelaxant. In 38 overweight individuals, the 
effect of natural honey on total cholesterol, LDL-C, high-density lipoprotein 
cholesterol (HDL-C), triacylglycerole, C-reactive protein (CRP), fasting blood 
glucose and body weight were investigated. The results showed that receiving 
70 g of natural honey for 30 days caused reduction in total cholesterol, LDL-C, 
triacylglycerole and CRP (P<0.05).  
Al-Jabri AA.(2001)  an experimental  study conducted in Riyadh  
among 23 diabetic patients. The use of honey in type I and type II diabetes was 
associated with significantly lower glycemic index than with glucose or sucrose 
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in normal diabetes. Honey compared with dextrose caused a significantly lower 
rise in plasma glucose levels in diabetic subjects. It also caused reduction of 
blood lipids, homocysteine levels and C-reactive protein (CRP) levels in 
normal and hyperlipidemic subjects. In earlier observations, it was found that 
honey stimulates insulin secretion, decrease blood glucose levels, elevates 
haemoglobin concentration and improves lipid profile52. 
2.2 Conceptual framework  
                         The conceptual framework for research study presents the 
reasoning, on which the purposes of the proposed study based. The framework 
provides the perspective from which the investigator views the problem. The 
present study is focused on the administration of honey to the constipated 
antenatal mothers to improve the elimination pattern. The investigator adopted 
WKH³0RGLILHG:LHGHQEDFK¶V+HOSLQJ$UWRI&OLQLFDO1XUVLQJ7KHRU\´
as a base for developing the conceptual frame work.  
7KH LQYHVWLJDWRU DGRSWHG WKH:HLGHQEDFK¶V +HOSLQJ $UW RI &OLQLFDO
Nursing Theory53 (1964) as a base for developing the conceptual 
framework. This theory directs on action towards an explicit goal. 
 It has 3 factors: 
1. Central purpose 
2. Prescription 
3. Realities 
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1. Central Purpose 
It refers to what the nurse wants to accomplish. It is the overall 
goal towards which a nurse strives. In this study the main central 
purpose is to assess the effectiveness of honey on constipation among 
antenatal mothers in third trimester. 
2. Prescriptions 
                        ,WUHIHUVWRWKHUHVHDUFKHU¶VSODQRIFDUHRULQWHUYHQWLRQWRPHHW
client need. It will specify the nature of action that will IXOILOWKHQXUVHV¶
central purpose. This includes the administration of 10 ml of honey in 100ml 
of warm water twice a day for three consecutive days among constipated 
antenatal women to the experimental group and assess the clients on 4th day 
for the level of constipation in both the groups. 
3. Realities 
 It refers to physical, physiological, emotional and spiritual 
factors that affect the nursing action. The five realities identified by 
:HLGHQEDFK¶V WKHRU\ DUH DJHQW UHFLSLHQW JRDO PHDQV DFWLYLWLHV DQG
framework. 
The conceptualization of nursing practice according to this theory 
consists of three steps: 
Step-1:  Identifying the need for help 
Step-2: Ministering the needed help 
Step-3: Validating the help 
Step-I- :  Identifying the need for help 
This step involves determining the need for help. The determination 
of the need for help is done by the process of sample selection on the basis of 
inclusive and exclusive criteria followed by the pre assessment of level of 
constipation among antenatal mothers in III trimester.  
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Step-2: Ministering the needed help 
This step involves provision of required help for identified need. 
It has two components. 
a. Prescriptions 
 
5HIHUV WR WKH LQYHVWLJDWRU¶V SODQ RI FDUH RU LQWHUYHQWLRQ WR PHHW WKH
FOLHQWV¶QHHG7KLVincludes the administration of 10 ml of honey in 100 
ml of warm water twice a day for three consecutive days among 
constipated antenatal women in third trimester. 
b. Realities:  
 
           This theory constitutes that the following element: 
Agent:           Investigator 
Recipient:     Patients with complaints of constipation. 
Goal:  To improve bowel elimination pattern.  
Means: 
x Experimental group: To assess the level of constipation and 
administration of honey. 
x Control group:  To assess the level of constipation and giving 
routine care. 
Activities:  The nurse validates the ministered help. It is accomplished 
by means of post assessment of the effectiveness of honey in relieving 
constipation among antenatal mothers in third trimester on 4 th day after 
administration of honey to the experimental group. Then the 
effectiveness of the intervention is compared between the experimental 
and control group. 
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Frame work:     Antenatal wards in Institute of Obstetrics and Gynaecology 
and Govt hospital for women and children. 
Step III : Validating the need for help is met 
 Validating the needed help is met. This is done by the post assessment 
using The Constipation Assessment Scale for Pregnancy (Broussard). It is an 
adaptation of the Constipation Assessment Scale of McMillan and William. It 
includes the signs and symptoms of constipation such as, Abdominal distension 
or bloating, Change in amount of gas passed rectally, Less frequent bowel 
movements, Oozing liquid stool, Rectal fullness or pressure, Rectal pain with 
bowel movement, Small volume of stool, Unable to pass stool. It was used to 
assess the level of constipation. Then the effectiveness of the intervention 
is compared between the experimental and control group.
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CHAPTER-III 
RESEARCH METHODOLOGY 
  The methodology involves a systematic procedure by which the researcher 
starts from the initial identification of the problem to its final conclusion. This study 
was conducted to assess the effectiveness of honey on constipation among antenatal 
mothers in third trimester admitted   in Institute of Obstetrics and Gynaecology and 
Govt hospital for women and children, Chennai.  
3.1 Research approach  
A quantitative approach was adopted in this study as the investigation is aimed 
to assess the effectiveness of honey to relieve constipation among antenatal mothers in 
third trimester. 
3.2 Data collection period 
The period of data collection was four weeks from 16.07.2015 to 15.08.2015. 
3.3 Study setting  
The study was conducted in antenatal wards at IOG, Chennai. It is a 1075 
bedded maternity hospital, started on 26th July 1844 for public service.  Being a 
tertiary referral centre, all high risk obstetric cases are managed with utmost care and 
high tech skills by an efficient team. A well equipped intensive care unit and 24 hours 
blood bank services also play a major role in preventing maternal deaths. It has been 
recognised as a centre of excellence. Various departments such as neonatal intensive 
care unit, family planning services, oncology department and genetic department were 
renovated. It provides comprehensive care for entire TamilNadu and neighbouring 
states like Andhra Pradesh.  
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3.4 Study design  
Quasi ± experimental Design 54(Non- randomized control group design) 
 
 
 
 
 
 
 
3.5 Study population  
Antenatal mothers in third trimester with constipation admitted in antenatal 
ward in Institute of Obstetrics and Gynaecology and Govt hospital for women and 
children, Chennai. 
3.6 Sample size 
The sample size for the study comprised of 60 antenatal mothers in third 
trimester with constipation. Out of which 30 samples for experimental group and 30 
samples for control group were allotted. 
3.7 Sample selection criteria   
 
3.7.1 Inclusion Criteria  
x Antenatal mother in third trimester with constipation. 
x Antenatal mothers of all age group. 
x Both primi and multigravida mothers. 
x Who are willing to participate in the study. 
 
 
Non Random 
Assignment 
Experimental 
Group 
(No: 30) 
Control 
group (No:30) 
Intervention 
10ml of honey 
in 100 ml of 
warm water 
Post test 
on 4thday 
Post test on 
4th  day 
Pre test on 
day 1 
Pre test on 
day 1 
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3.7.2 Exclusion criteria  
x Antenatal mothers who have not given consent for the study. 
x Antenatal mothers who are having other associated problem with 
constipation.   
x Antenatal mother with other systemic illness, eclampsia, severe PIH  and 
GDM.  
x Antenatal mothers with hypothyroidism, chronic constipation, habitual 
constipation.  
3.8 Sampling technique   
Non probability purposive sampling technique was used to select the samples. 
The investigator selected the samples from two antenatal wards; experimental group 
from Ward No: 1 and control group from Ward No: 2, this technique was used to 
prevent contamination like sharing of information between the two groups. 
3.9 Research variables  
Independent variable- honey administration  
Dependent variable ± antenatal mothers in third trimester with constipation  
3.10. Development and description of the tool  
3.10.1 Development of the tool  
Tool is developed after extensive review of literature from various text book, 
journals, internet search, discussion and guidance from the experts in the field of 
medical and nursing from Department of Obstetrics and Gynaecology. 
3.10.2 Description of the tool  
Section ±A comprised of demographic variables like age, educational status, 
occupation, monthly income, religion, residence, type of family.   
Section -B comprised of obstetric variables like gravida, gestational age, and 
registration in antenatal clinic. 
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Section ±C comprised of personal variables like bowel habits, fluid intake, dietary 
pattern, daily activities, relieving measures.   
 Section-D comprised of clinical variables which are given in the constipation 
assessment scale for pregnancy. It is an adaptation of the Constipation Assessment 
Scale of McMillan and Williams55 (Broussard, 1998). It includes the signs and 
symptoms of constipation such as, abdominal distension or bloating, change in 
amount of gas passed rectally, less frequent bowel movements, oozing liquid stool, 
rectal fullness or pressure, rectal pain with bowel movement, small volume of stool, 
unable to pass stool. It was used to assess the level of constipation.  
Scoring key  
The constipation level was assessed using constipation assessment scale on 
eight variables.  
The scores are as follows. 
Clinical variables  
a) None-0 
b) Mild-1 
c) Moderate-2 
d) Severe-3 
e) Very Severe-4 
Maximum score 32 
Minimum score 0 
Score interpretation  
None to Minimal=0-8 
Minimal to Moderate=9-17 
Moderate to Severe= >25 
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Intervention protocol  
 Experimental group Control group 
Place 
 
Antenatal ward Antenatal ward 
Dose Honey 10 ml added in 100 ml 
of warm water. 
 
Routine care  
Duration 3 days 
 
3 days 
 
Frequency 
 
Twice a day - 
Time 7.30 am & 9.00pm 
 
- 
Administered by Morning dose by the 
investigator and evening dose 
by the client itself. 
 
- 
Recipient Antenatal mothers in third 
trimester with constipation 
Antenatal mothers in 
third trimester with 
constipation 
 
3.10.3 Content validity  
Content validity is a case of expert judgement about the content area included 
in the research instrument to measure a particular phenomenon based on previous 
UHVHDUFKHV DQG H[SHUWV¶ RSLQLRQ DERXW WKH DGHTXDF\ DSSURSULDWHQHVV DQG
completeness of the content of instrument.     
After construction of questionnaire, validity of the tool was assessed using 
content validity. Content validity was determined by experts from medical, statistician 
and nursing field. They suggested some modifications in the tool. After the 
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modification they agreed this tool for assessing effectiveness of honey on constipation 
among antenatal others in third trimester. 
3.11 Ethical consideration  
The study objectives, intervention and data collection procedure were approved 
by the research and ethical committee of the institution. The research proposal was 
approved by the experts prior to the pilot study and permission for the main study was 
obtained from the Director and Head of the Institution of Obstetrics and Gynaecology, 
Chennai.  Informed consent was obtained from each antenatal mother in third 
trimester with constipation before starting the data collection. Assurance was given for 
confidentiality and privacy. 
3.12 Pilot study  
Pilot study is a trail run for the main study, to test the reliability, practicability 
and feasibility of the study. The pilot study was conducted in antenatal wards of IOG, 
Chennai. Antenatal mothers in third trimester with constipation were selected for pilot 
study, five women for each experimental and control group respectively. Non 
probability purposive sampling technique was used. Honey mixture was administered 
to the experimental group. The result showed that the level of constipation decreased 
in the post assessment. The tool was feasible and practical to administer and hence no 
further modification was done.  
3.13 Reliability of the tool 
After pilot study reliability of the tool was assessed by using split half method 
and its correlation coefficient r ±value is 0.83. This correlation coefficient is very high 
and it is an adequate tool for assessing effectiveness of honey on constipation.  
3.14 Data collection procedure 
The antenatal mothers in third trimester with constipation were assured that the 
data collected will be kept confidential and data collection was done four weeks. 
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Phase ±I 
Screenings of the subjects were done with the help of constipation assessment 
scale for pregnancy (Broussard) and information was collected with the questionnaire. 
Samples selected by purposive sampling technique and they were divided into two 
groups, experimental and control with 30 subjects in each group. Pre-assessment of 
constipation level was assessed for both the group.  
Phase II 
The investigator selected the samples from two antenatal wards; experimental 
group from Ward No: 1 and control group from Ward No: 2. Purposive sampling 
technique was used to prevent sharing of information between samples. Experimental 
group received 10 ml honey in 100 ml of warm water twice a day for three 
consecutive days and for control group routine care was given. The investigator took 
two to three samples per day and spent about 20 minutes to each sample to clarify 
their doubts. Post assessment was done on fourth day for both experimental and 
control group using the same tool. 
3.15 Data entry and analysis 
 The data were analyzed by descriptive statistical methods like mean, standard 
deviation, frequency percentage and inferential statistical methods like  
independent chi square and t-test. Analysed data were presented by tables and 
diagrams. 
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  FIGURE-3.1: Schematic representation of research study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Quantitative approach 
Administration of 10ml of honey 
in 100 ml of warm water twice a 
day for 3 consecutive days 
                                         Quasi experimental study   
Study setting: Antenatal ward at IOG,  Chennai. 
 Population : Antenatal mothers in third trimester with constipation  
Sampling technique:  Non probability purposive sampling technique 
Sample Size 60 (30 for experimental group and 30 for  
control group 
Control Group Experimental Group 
Routine care 
Data Analysis and Interpretation with Descriptive and Inferential 
Statistics 
Dissemination of the findings and Recommendation 
Post assessment of level of 
constipation  
Post assessment of level of 
constipation  
Pre Assessment 
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CHAPTER-IV 
DATA ANALYSIS AND INTERPRETATION 
   This chapter deals with the statistical analysis and interpretation of the data 
collected from constipated antenatal mothers in third trimester admitted in antenatal 
ward at Institute of Obstetrics and Gynaecology and Govt hospital for women and 
children, Chennai.  
The researcher used descriptive and inferential statistics for analysis. The data 
were analyzed, tabulated and interpreted by using descriptive and inferential statistics 
in the sequence as follows.  
 The data deals with the demographic variables, obstetrical and personal  
variables, pre  and post  test assessment of  level of constipation by constipation 
assessment scale for pregnancy (Broussard).The data was assembled, analyzed, 
and tested for their significance using appropriate statistical methods and the 
results are presented below. 
Organization of the data 
Section ± 1: Distribution of sample in relation to variables. 
A. Distribution of frequency percentage in experimental and control group 
in relation to demographic variables. 
B. Distribution of frequency percentage in experimental and control group 
in relation to obstetric variables. 
C. Distribution of frequency percentage in experimental and control group 
in relation to personal variables. 
 
Section-2 
Level of constipation in pre-test and post-test among experimental and control group. 
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Section ± 3 
Comparison of level of constipation among experimental and control group.  
Section ± 4 
Effectiveness of honey on constipation among antenatal mothers in experimental 
group 
Section ± 5 
Association between level of constipation reduction among selected variables. 
a) Association between level of constipation reduction and demographic variable 
in experimental group. 
b) Association between level of constipation reduction among  personal variables 
in experimental group. 
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SECTION ± 1A) Demographic profile 
Table 4.1: Distribution of demographic variables 
Demographic variables 
 
 
Experimental(n=30) Control(n=30) 
frequency in % frequency in % 
Age in years 
 
 
20 -25 years 14 46.7 9 30.0 
26 -30 years 13 43.3 16 53.3 
31 -35 years 3 10.0 5 16.7 
Educational status 
 
 
 
No formal education 3 10.0 5 16.7 
Primary education 6 20.0 10 33.3 
Secondary education 14 46.7 9 30.0 
Graduate & post graduate 7 23.3 6 20.0 
Occupation 
 
 
Home maker 26 86.6 24 80.0 
Self employed 2 6.7 2 6.7 
Private employee 2 6.7 4 13.3 
Monthly income 
 
 
< Rs.5000 10 33.3 15 50.0 
Rs.5001 -10000 14 46.7 11 36.7 
> Rs.10,000 6 20.0 4 13.3 
Religion 
 
 
Hindu 26 86.7 21 70.0 
Muslim 2 6.7 5 16.7 
Christian 2 6.7 4 13.3 
Residence 
 
 
Rural 11 36.7 13 43.3 
Sub urban 9 30.0 12 40.0 
Urban 10 33.3 5 16.7 
Type of family 
 
Nuclear family 20 66.7 15 50.0 
Joint family 10 33.3 15 50.0 
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Among experimental group majority of the mothers came under the age group 
of 20-25 years (46.7%) and in control group majority of them came under the age 
group of 26-30 years (53.3%). Regarding the educational status in experimental group 
majority, 14 (46.7%) belonged to secondary education and in control group, 
10(33.3%) belonged to primary education. 
Regarding occupational status both in experimental group 26(86.6%) and in 
control group, 24(80%) belonged to homemaker. Regarding income of the 
experimental group 14(46.7%) under the Rs.5000-10000/- per month and in control 
group 15 (50%) under the Rs.>5000/- per month. Regarding religion majority of the 
mothers in experimental group 26(86.7%) and in control group 21(70%) were Hindus. 
Majority of the mothers in both experimental 11(36.7%) and control group, 
13(43.3%) were rural population. 
Considering the type of family in experimental group, 20 (66.7%) belonged to 
joint family and in control group both nuclear families and joint families (50%) 
participated in this study. 
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SECTION±1B) Obstetric variables 
 Table 4.2: Distribution of obstetric variables 
 obstetrical variable 
  
Experiment(n=30) Control(n=30) 
frequency in % frequency in % 
Gravida 
  
Primi 13 43.3 18 60.0 
Multi 17 56.7 12 40.0 
Gestational age 27-31 weeks 7 23.3 9 30.0 
  32-36 weeks 10 33.3 12 40.0 
  37-40 weeks 13 43.4 9 30.0 
Consumption of 
iron  tablets 
during 
pregnancy 
 
Regular 
27 90.0 27 90.0 
  Irregular 3 10.0 3 10.0 
 
Among experimental group, regarding the gravida of the mothers majority 17 
(56.7%) were multi gravida and in control group majority 18(60.0%) were primi 
gravida.  
Regarding gestational age among experimental group, majority 13(43.3%) 
were between 37-40 weeks and in control group majority 12(40%) were between 32-
36 weeks. Among experimental and control group, majority 27(90%) of mothers took 
tablets regularly during pregnancy.  
 
 
 
 
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Fi
gu
re
 4
.8
: G
ra
vi
da
 w
is
e 
di
st
ri
bu
tio
n 
of
 a
nt
en
at
al
 m
ot
he
rs
 
0%
 
10
%
20
%
 
30
%
 
40
%
 
50
%
 
60
%
 
70
%
 
80
%
 
90
%
 
10
0%
 
Pr
im
i
M
ul
ti
43
.3
%
 
56
.7
%
 
60
.0
%
 
40
.0
%
 
Antenatal mothers  
G
ra
vi
da
 
Ex
pe
rim
en
t 
C
on
tro
l 
 
Fi
gu
re
 4
.9
: G
es
ta
tio
na
l w
ee
k 
w
is
e 
di
st
ri
bu
tio
n 
of
 a
nt
en
at
al
 m
ot
he
rs
 
0%
 
10
%
 
20
%
 
30
%
 
40
%
 
50
%
 
60
%
 
70
%
 
80
%
 
90
%
 
10
0%
 
27
-3
1 
w
ee
ks
 
32
-3
6 
w
ee
ks
 
37
-4
0 
w
ee
ks
 
23
.3
%
 
33
.3
%
 
43
.4
%
 
30
.0
%
 
40
.0
%
 
30
.0
%
 
Antenatal mothers  
G
es
ta
tio
na
l w
ee
k 
Ex
pe
rim
en
t 
C
on
tro
l 
  
 
   
   
   
   
   
   
 F
ig
ur
e 
4.
10
: D
is
tr
ib
ut
io
n 
of
 c
on
su
m
pt
io
n 
of
 ir
on
 ta
bl
et
s a
m
on
g 
an
te
na
ta
l m
ot
he
rs
 
  
0%
 
10
%
 
20
%
 
30
%
 
40
%
 
50
%
 
60
%
 
70
%
 
80
%
 
90
%
 
Re
gu
la
r 
Irr
eg
ul
ar
 
90
%
 
10
%
 
90
%
 
10
%
 
Antenatal mothers 
   
 co
ns
um
pt
io
n 
of
 ir
on
 ta
bl
et
s 
Ex
pe
rim
en
ta
l 
co
nt
ro
l 
SECTION ± 1C) Personal variables  
Table 4.3: Distribution of personal variables 
Personal  variables 
  
Experiment(n=30) Control(n=30) 
frequency in % frequency in % 
Bowel habits Once in a 
day/two 
18 60.0 13 43.3 
  Thrice a week 10 33.3 14 46.7 
  Once / twice a 
week 
2 6.7 3 10.0 
Fluid intake >1500ml 4 13.3 6 20.0 
  <2000ml 7 23.3 9 30.0 
  >2000ml 19 63.3 15 50.0 
Dietary pattern Vegetarian 2 6.7 5 16.7 
  Non Vegetarian 4 13.3 7 23.3 
  Mixed 24 80.0 18 60.0 
Daily activities Regular walking 9 30.0 6 20.0 
  Once in  a while 6 20.0 9 30.0 
  Not at all 15 50.0 15 50.0 
Knowledge of 
health 
benefits of 
honey 
  
Yes 18 60.0 20 66.7 
 
 
No 
 
12 
 
40.0 
 
10 
 
33.3 
Relief measures Home remedies 19 63.3 17 56.7 
  Medical help 2 6.7 4 13.3 
   
None 
9 30.0 9 30.0 
 
       
 
   In experimental group, regarding bowel habit of the mothers, majority 
18(60.0%) had bowel habits of once in a day/two and in control group, 14(46.7%) of 
had bowel habits of thrice in a week. Considering fluid intake in experimental group 
19(63.3%) were >2000ml and among control group 15(50%) were >2000ml per day.  
        Regarding dietary pattern among experimental group majority 24(80%) of the 
mothers and in control group, 18(60%) were mixed diet. Regarding the daily activities 
in both experimental and control group (15) 50% of mothers not at all doing any 
exercises.  
         Among experimental group majority of the mother (18) 60% and in control 
group 20(66.7%) had knowledge about health benefits of honey. Regarding relieving 
measures for constipation both experimental group (19) 63.3%   and control group 
(17) 56.75% took home remedies. 
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Section 2) Level of constipation in pre-test and post-test among 
experimental and control group. 
Table 4.4 Pre-test level of constipation in relation to sign and symptoms  
 of constipation 
Clinical signs and symptoms of constipation 
Maximum  
score Mean SD constipation score  
 Experimental 
group 
Abdominal distension or bloating 
4 0.77 
 
.84 19.3% 
    Change in amount of gas passed 
rectally 
 
4 0.4 
 
.63 10.0% 
    Less frequent bowel movements 4 1.6 .68 40.0% 
    Oozing liquid stool 4 0 .00 0.0% 
    Rectal fullness or pressure 4 2.95 .56 73.8% 
    Rectal pain with bowel movement 4 0.37 .76 9.3% 
    Small volume of stool 4 2.4 .77 60.0% 
    Unable to pass stool 4 2.58 .45 64.5% 
     
Total 32 
 
11.07 
 
2.75 
 
34.6% 
  Control group Abdominal distension or bloating 4 0.98 .91 24.5% 
 Change in amount of gas passed 
rectally 
4 
.53 .93 
13.3% 
Less frequent bowel movements 4 1.53 1.01 38.3% 
Oozing liquid stool 4 .00 .00 0.0% 
Rectal fullness or pressure 4 2.93 .69 73.3% 
Rectal pain with bowel movement 4 .50 .82 12.5% 
 Small volume of stool 4 2.40 .63 60.0% 
   Unable to pass stool 4 2.60 .62 65.0% 
     
 
Total 32 
 
 
11.47 
 
 
2.11 35.8% 
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Among experimental group in relation to signs and symptoms of constipation 
in pre-test majority of the mother 73.8% had rectal fullness or pressure, 64.5% had 
unable to pass stool, 60.0% had small volume of stool, 40.0% had less frequent bowel 
movements, 19.3% had abdominal distension or bloating, 10% had change in amount 
of gas passed rectally, 9.3% had rectal pain with bowel movements and none of them 
had oozing liquid stool. In pre-test, total constipation score was 34.6%. 
Among control group in relation to signs and symptoms of constipation, in 
pre-test majority of the mother 73.3% had rectal fullness or pressure, 65.0% had 
unable to pass stool, 60.0% had small volume of stool, 38.3% had less frequent bowel 
movements, 24.4% had abdominal distension or bloating, 13.3% had change in 
amount of gas passed rectally, 12.5% had rectal pain with bowel movements and none 
of them had oozing liquid stool. In control group total constipation score was 35.8%. 
 
 Fi
gu
re
 4
.1
6:
 P
re
-t
es
t l
ev
el
 o
f c
on
st
ip
at
io
n 
in
 r
el
at
io
n 
to
 si
gn
s a
nd
 sy
m
pt
om
s 
0%
 
10
%
 
20
%
 
30
%
 
40
%
 
50
%
 
60
%
 
70
%
 
80
%
 
Abdominal distension or 
bloating 
Change in amount of gas 
passed rectally 
Less frequent bowel 
movements 
Oozing liquid stool 
Rectal fullness or pressure 
Rectal pain with bowel 
movement 
Small volume of stool 
Unable to pass stool 
19
.3
%
 
10
.0
%
 
40
.0
%
 
0.
0%
 
73
.8
%
 
9.
3%
 
60
.0
%
 
64
.5
%
 
24
.5
%
 
13
.3
%
 
38
.3
%
 
0.
0%
 
73
.3
%
 
12
.5
%
 
60
.0
%
 
65
.0
%
 
Antenatal mothers  
Si
gn
s a
nd
 sy
m
pt
om
s  
 
Ex
pe
rim
en
t 
C
on
tro
l 
44 
 
Table 4.5: Pre-test level of constipation in relation to constipation score 
Level of constipation 
  
Experimental Control 
Chi square test frequency  in % frequency  in % 
 None to Minimal 3 10.0 4 13.3 
F2=0.16 p=0.68  
DF=1  
  Minimal  to Moderate 27 90.0 26 86.7 
  Moderate to Severe 0 0.0 0 0.0 
   Total 30 100. 30 100.  
 
In pre-test, among experimental group, 10.0% of the antenatal mothers had 
none to minimal score, 90.0% of them had minimal to moderate score.  
Among control group, 13.3% of the antenatal mothers had none to minimal 
score, 86.7% of them had minimal to moderate score. Statistically there was no 
significant difference between experimental and control group. It was confirmed using 
chi square test. 
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             Table 4.6: Post-test level of constipation in relation to    
                                signs and symptoms of constipation 
 Signs and symptoms of constipation 
Maximum  
score Mean SD 
  constipation 
score  
Experimental 
group 
  
  
  
  
  
  
  
  
  
  
  
  
Abdominal distension or bloating 
4 
 
0.33 
 
.61 8.3% 
Change in amount of gas passed rectally  
4 
 
0.00 
 
.00 0.0% 
Less frequent bowel movements 4 0.65 .81 16.3% 
Oozing liquid stool 4 0.00 .00 0.0% 
Rectal fullness or pressure 4 1.13 .89 28.3% 
Rectal pain with bowel movement  
4 
 
0.00 
 
.00 0.0% 
Small volume of stool 4 0.79 0.94 19.8% 
Unable to pass stool 4 0.97 1.03 24.3% 
 
Total 32 
 
3.87 
 
2.92 12.1% 
  
Control 
group 
  
  
  
  
  
  
  
  
  
Abdominal distension or bloating 4 0.93 .87 23.3% 
Change in amount of gas passed rectally 4 0.37 .76 9.3% 
Less frequent bowel movements 4 1.27 .90 31.8% 
Oozing liquid stool 4 0.00 .00 0.0% 
Rectal fullness or pressure 4 2.40 .76 60.0% 
Rectal pain with bowel movement 4 0.20 .61 5.0% 
Small volume of stool 4 2.23 .81 55.8% 
Unable to pass stool 4 2.20 .79 55.0% 
 
Total 
32 
 
9.60 
 
3.25 
30.3% 
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In post test, among experimental group the signs and symptoms of 
constipation percentage reduced after honey administration. Abdominal distension or 
bloating 8.3%, less frequent bowel movements 16.3%, rectal fullness or pressure 
28.3%, unable to pass stool 24.3%, small volume of stool 19.8%, and none of them 
complaint of  change in amount of gas passed rectally and rectal pain with bowel 
movements. In post-test, total constipation score was 12.1%. 
In post test, among control group in relation to signs and symptoms of 
constipation in post-test, abdominal distension or bloating 23.3%, change in amount 
of gas passed rectally 9.3%, less frequent bowel movements 31.8%, rectal fullness or 
pressure 60 %, rectal pain with bowel movements 5.0% unable to pass stool 55%, 
small volume of stool 55.8%. In post-test, total constipation score was 30.3%. 
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Table 4.7: Post-test level of constipation in relation to 
                      constipation score 
 Level of constipation 
  
Experimental Control 
Chi square test frequency  in % frequency  in % 
 None to Minimal 25 83.3 12 40 
F2=11.91 P=0.001***  
DF=1   
Minimal to Moderate 5 16.7 18 60 
Moderate to Severe 0 0.0 0 0.0 
         Total 30 100 30 100 
 
x VLJQLILFDQWDW3 
x KLJKO\VLJQLILFDQWDW3 
x YHU\KLJKVLJQLILFDQWDW3 
 
In post-test, among experimental group, 83.3% of antenatal mothers were in 
none to minimal score, 16.7% of them were minimal to moderate score.  
          Among control group, 40.0% of the antenatal mothers were in none to minimal 
score, 60.0% of them were in minimal to moderate score. It was confirmed using chi 
square test F2=11.91 P=0.001. Statistically there is significant difference between 
experimental and control group 
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SECTION 3: Comparison of level of constipation among  
                    experimental and control group. 
Table 4.8: Comparison of pre-test and post-test in experimental group 
 
x VLJQLILFDQWDW3 
x KLJKO\VLJQLILFDQWDW3 
x  YHU\KLJKO\VLJQLILFDQWDW3   
 
  Pre-test and post-test mean constipation score among experimental 
group mothers were analyzed using student paired t-test. It is statistically 
significant. 
  
 
 
 
          
Signs and symptoms 
  
Pretest Posttest 
 
Mean 
 
difference 
 
Student Paired t-test 
Mean SD Mean SD 
Abdominal distension or 
bloating 0.77 
 
.84 
 
0.33 
 
.61         0.44 
t=3.67 p=0.01**  
Change in amount of gas passed  0.4 .63 0.00 .35 0.40 t=2.36 p=0.05*  
Less frequent bowel movements 1.6 .68 0.65 .81 0.95 t=4.82 p=0.001***  
Oozing liquid stool 0 .00 0.00 .00 0.00 t=0.00 p=1.00  
Rectal fullness or pressure 2.95 .56 1.13 .89 1.82 t=11.08 p=0.001***  
Rectal pain with bowel 
movement 0.37 
 
.76 
 
0.00 
 
.25 0.37 
t=2.19 p=0.05*   
Small volume of stool 2.4 .77 0.79 1.03 1.61 t=9.14 p=0.001***  
Unable to pass stool 2.58 .45 0.97 .94 1.61 t=9.25 p=0.001***  
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Table  4. 9: Comparison of pre-test and post-test among control  
             group 
Signs and 
symptoms 
  
Pretest Posttest Mean  
difference 
 
Student Paired t-
test 
Mea
n SD Mean SD 
Abdominal 
distension /bloating 0.98 .91 0.93 .87 
  
0.05  
 t=0.10 p=0.88   
Change in amount of 
gas passed  
.53 .93 0.37 .76 
0.16 
 t=1.17 p=0.27   
Less frequent bowel 
movements 
1.53 1.01 1.27 .90 
0.26 
 t=1.48 p=0.17   
Oozing liquid stool .00 .00 0.00 .00 0.00 t=0.00 p=0.00   
Rectal fullness or 
pressure 
2.93 .69 2.40 .76 
0.53 
t=1.91 p=0.06  
Rectal pain with 
bowel movement 
.50 .82 0.20 .61 
0.30 
 t =1.59 p=0.10   
Small volume of 
stool 
2.40 .63 2.23 .81 
0.17 
 t=1.61 p=0.18  
Unable to pass stool 2.60 .62 2.20 .79          0.40  t=1.84 p=0.07  
 
Pre-test and post-test mean constipation score among control group mothers 
were analyzed using student paired t-test. It is not statistically significant. 
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Table  4. 10: Comparison of experimental and control group 
 Constipation  
score 
Mean 
difference 
Student 
paired 
 t-test Mean SD 
Experimental pre-test 11.07 2.75  
7.20 
t=14.79 
p=0.001 ***  post-test 3.87 2.92 
Control pre-test 11.47 2.11  
1.87 
t=1.94 
p=0.06  post-test 9.60 3.25 
 
x VLJQLILFDQWDW3 
x KLJKO\VLJQLILFDQWDW3 
x  YHU\KLJKO\VLJQLILFDQWDW3   
 
In pre-test among experimental group, mean constipation score was 11.07 and 
in post-test score was 3.87. Difference was 7.20 score. The difference between pre-test 
and post-test was t=14.79, p value=0.001 and it is statistically significant. Difference 
between pre-test and post-test score was analysed using Student paired t-test.  
In pre-test among control group, mean constipation score was 11.47 and post-
test score was 9.60 and difference was 1.87 score.  The difference between pre-test 
and post-test score was small and it was not statistically significant. Difference 
between pre-test and post-test score was analysed using Student paired t-test. 
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Table  4. 10: Comparison of experimental and control group 
 Constipation  
score 
Mean 
difference 
Student 
paired 
 t-test Mean SD 
Experimental pre-test 11.07 2.75  
7.20 
t=14.79 
p=0.001 ***  post-test 3.87 2.92 
Control pre-test 11.47 2.11  
1.87 
t=1.94 
p=0.06  post-test 9.60 3.25 
 
x VLJQLILFDQWDW3 
x KLJKO\VLJQLILFDQWDW3 
x  YHU\KLJKO\VLJQLILFDQWDW3   
 
In pre-test among experimental group, mean constipation score was 11.07 and 
in post-test score was 3.87. Difference was 7.20 score. The difference between pre-test 
and post-test was t=14.79, p value=0.001 and it is statistically significant. Difference 
between pre-test and post-test score was analysed using Student paired t-test.  
In pre-test among control group, mean constipation score was 11.47 and post-
test score was 9.60 and difference was 1.87 score.  The difference between pre-test 
and post-test score was small and it was not statistically significant. Difference 
between pre-test and post-test score was analysed using Student paired t-test. 
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SECTION 3: Effectiveness of honey on constipation  
 Table 4.12:  Effectiveness of honey in reduction of signs and  
                          symptoms of constipation 
 
   In experimental group the difference between pre-test and post-test was  
22.5 % and in control group 5.5%. This shows the effectiveness honey in relieving 
constipation.  
. 
 
 
 
 
 
 
 
 
 
 
 
 
          
  Signs and symptoms 
Experimental Control 
Pre-
test 
Post-
test 
Difference Pre-
test 
Post-
test 
Difference 
Abdominal distension or bloating 19.3% 8.3% 11.0% 24.5% 23.3% 1.2% 
Change in amount of gas passed 
rectally 10.0% 0.0% 10.0% 13.3% 9.3% 4.0% 
Less frequent bowel movements 40.0% 16.3% 23.7% 38.3% 31.8% 6.5% 
Oozing liquid stool 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
Rectal fullness or pressure 73.8% 28.3% 45.5% 73.3% 60.0% 13.3% 
Rectal pain with bowel movement 9.3% 0.0% 9.3% 12.5% 5.0% 7.5% 
Small volume of stool 60.0% 19.8% 40.2% 60.0% 55.8% 4.2% 
Unable to pass stool 64.5% 24.3% 40.2% 65.0% 55.0% 10.0% 
             OVERALL 34.6% 12.1% 22.5% 35.8% 30.3% 5.5% 
Table  4. 13: Effectiveness of honey in reduction of constipation  
 
 
 
Group 
 Max 
score 
Mean 
constipation 
score 
Mean Difference in 
constipation  score  
with 95% 
Confidence interval 
Percentage 
difference of   
constipation  score 
with 95% 
Confidence interval 
Experimental Pre-test 32 11.07 7.20(6.55 ± 7.85) 22.5 % (20.5% ±
24.5%) Post-test 32 3.87 
Control Pre-test 32 11.47 1.87(0.36 ± 3.37) 5.8% (1.1% ±10.5%) 
Post-test 32 9.60 
 
 In experimental group, mean difference between pre-test and post-test 
constipation score was 7.20 and percentage difference of constipation 22.5% (95% CI 
20.5%±24.5%). This shows the effectiveness of honey in relieving constipation. 
Among control group mothers, mean difference between pre-test and post-test 
constipation score was 1.87 and percentage difference of constipation 5.8% (95% CI 
1.1% ±10.5%). 
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SECTION ± 5) Association between level of constipation reduction 
   among selected variables. 
Table 4.14: Association between demographic variables in experimental  
 group 
Demographic variables 
Constipation reduction score 
Total Chi square test 
Below 
DYHUDJH 
Above 
average(>7.20) 
frequency in % frequency in % 
Age in years 20 -25 years 3 21.4% 11 78.6% 14 
F2=8.67 p=0.01** 
DF=2   
26 -30 years 10 76.9% 3 23.1% 13 
31 -35 years 2 66.7% 1 33.3% 3 
Educational 
status 
No formal 
education 
3 100.0% 0  0.0%  3 
F2=8.73p=0.05* 
DF=3   
Primary 
education 
4 66.7% 2 33.3% 6 
Secondary 
education 
7 50.0% 7 50.0% 14 
Graduate & post 
graduate 
1 14.2% 6 85.8% 7 
Occupation Home maker 12 46.2% 14 53.8% 26 
F2=2.15 p=0.34 
DF=2  
Self employed 2 100.0% 0  0.0%  2 
Private employee 1 50.0% 1 50.0% 2 
Monthly 
income 
< Rs.5000 4 40.0% 6 60.0% 10 
F2=0.68 p=0.71 
DF=2  
Rs.5001 -10000 8 57.1% 6 42.9% 14 
> Rs.10,000 3 50.0% 3 50.0% 6 
Religion Hindu 13 50.0% 13 50.0% 26 
F2=4.00 p=0.13 
DF=2  
Muslim 2 100.0% 0  0.0%  2 
Christian 0  0.0%  2 100.0% 2 
Residence Rural 6 54.5% 5 45.5% 11 
F2=2.69 p=0.26 
DF=2  
Sub urban 6 66.7% 3 33.3% 9 
Urban 3 30.0% 7 70.0% 10 
Type of 
family 
Nuclear family 13 65.0% 7 35.0% 20 
F2=5.40 p=0.02* 
DF=1  
Joint family 
2 20.0% 8 80.0% 10 
 
Younger age mothers (20-25) years (F2=8.67 p=0.01), more educated 
(F2=8.73p=0.05) and joint family mothers (F2=5.40 p=0.02) were benefitted 
more than others. Statistical significance was calculated using chi square test.  
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Table 4.15: Association between level of constipation reduction in selected 
obstetric variables among antenatal mothers in experimental group 
Obstetrical variables 
  
  
Constipation reduction score 
Total 
Chi 
square 
test 
Below 
DYHUDJH 
Above 
average(>7.20) 
frequency 
in 
% frequency 
in 
% 
Gravida Primi 
7 
53.
8% 
6 
46.
2% 
13 F2=0.13 
p=0.71 
DF=2  
  Multi 
8 
47.
1% 
9 
52.
9% 
17 
Gestational 
age 
27-31 
weeks 
3 
42.
8% 
4 
57.
2% 
7 
F2=2.43 
p=0.30 
DF=2   
  32-36 
weeks 
7 
70.
0% 
3 
30.
0% 
10 
  37-40 
weeks 
5 
38.
4% 
9 
61.
6% 
13 
Consumption 
of iron tablets 
during 
pregnancy 
 
Regular 
12 
44.
4% 
15 
55.
6% 
27 
F2=3.33 
p=0.07 
DF=2 
not 
significa
nt 
  Irregular 
3 
100
.0% 
    3 
 
      In experimental group none of the obstetric variables gravida, gestational age, 
consumption of iron tablets during pregnancy was significant. Statistical significance 
was calculated using chi square test. 
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Table 4.16: Association between level of constipation reduction in selected 
personal variables among antenatal mothers in experimental group 
Personal variables 
Constipation reduction score 
Total Chi square test 
Below 
DYHUDJH 
Above 
average(>7.20) 
frequency in % frequency in % 
Bowel habits Once in a 
day/two 
6 33.3% 12 66.7% 18 
F2=6.60 
p=0.05* DF=2  
Thrice a week 7 70.0% 3 30.0% 10 
Once / twice a 
week 
2 100.0% 0  0.0%  2 
Fluid intake >1500ml 3 75.0% 1 25.0% 4 
F2=1.61 
p=0.44 DF=2  
<2000ml 4 57.1% 3 42.9% 7 
>2000ml 8 42.1% 11 57.9% 19 
Dietary pattern Vegetarian 1 50.0% 1 50.0% 2 
F2=1.16 
p=0.56 DF=2  
Non 
Vegetarian 
1 25.0% 3 75.0% 4 
Mixed 13 54.2% 11 45.8% 24 
Daily activities Regular 
walking 
2 22.2% 7 77.8% 9 
F2=6.71 C 
DF=2   
Once in  a 
while 
2 33.3% 4 66.7% 6 
Not at all 11 73.3% 4 26.7% 15 
Knowledge of health 
benefits of honey 
Yes 8 44.4% 10 55.6% 18 F2=0.55 
p=0.45 DF=2  No 7 58.3% 5 41.7% 12 
Relief measures Home 
remedies 
8 42.1% 11 57.9% 19 
F2=1.47 
p=0.48 DF=2  Medical help 1 50.0% 1 50.0% 2 
None 6 66.7% 3 33.3% 9 
Among personal variables, once in a day/ two bowel habits (p=0.05), regular 
walking mothers (p=0.05) are benefitted more than others. Statistical significance 
was calculated using chi square test. 
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Table 4.17: Association between level of constipation reduction 
among antenatal mothers in demographic variables in control group 
Demographic variables 
  
  
Constipation reduction score 
Total 
Chi 
square 
test 
Below 
DYHUDJH 
Above 
average(>1.87) 
frequency in % frequency in % 
Age in years 20 -25 years 3 33.3 6 66.7 9 F2=1.45 
p=0.48 
DF=2 
  26 -30 years 9 56.3 7 43.7 16 
  31 -35 years 3 60.0 2  40.0 5 
Educational status No formal education 2 40.0 3 60.0 5 
F2=0.71 
p=0.87 
 DF=3   
  Primary education 6 60.0 4 40.0 10 
  Secondary education 4 44.4 5 55.6 9 
  Graduate & post graduate 3 50.0 3 50.0 6 
Occupation Home maker 13 54.2 11 45.8 24 F2=2.16 
p=0.34  
DF=2  
  Self employed  0  0.0 2 100.0 2 
  Private employee 2 50.0 2 50.0 4 
Monthly income < Rs.5000 9 60.0 6 40.0 15 F2=1.68 
p=0.43 
 DF=2  
  Rs.5001 -10000 5 45.5 6 54.5 11 
  >Rs.10,000 1 25.0 3 75.0 4 
Religion Hindu 10 47.6 11 52.4 21 F2=0.24 
p=0.88  
DF=2  
  Muslim 3 60.0 2 40.0 5 
  Christian 2 50.0 2 50.0 4 
Residence Rural 6 46.2 7 53.8 13 F2=0.27 
p=0.87  
DF=2  
  Sub urban 6 50.0 6 50.0 12 
  Urban 3 60.0 2 40.0 5 
Type of family Nuclear family 7 46.7 8 53.3 15 F2=0.13 
p=0.71  
DF=1  
  Joint family 
8 53.3 7 46.7 15 
 
In control group none of the demographic variables were significant. Statistical 
significance was calculated using chi square test. 
58 
 
 
Table 4.18: Association between level of constipation reduction 
among antenatal mothers in obstetric variables in control group 
Obstetrical variables 
  
  
Constipation reduction score 
Total 
Chi 
square 
test 
Below 
DYHUDJH 
Above 
average(>1.87) 
frequency % frequency % 
Gravida Primi 8 44.4 10 55.6 18 F2=0.55 
p=0.45 
DF=2 
  Multi 
7 58.3 5 41.7 12 
Gestational 
age 
27-31 
weeks 
6 66.7 3 33.3 9 
F2=2.44 
p=0.29 
DF=2   
  32-36 
weeks 
4 33.3 8 66.7 12 
  37-40 
weeks 
5 55.6 4 44.4 9 
Consumption 
of iron tablets 
during 
pregnancy 
 
Regular 
13 48.1 14 51.9 27 
F2=0.37 
p=0.54 
DF=2  
 Irregular 2 66.7 1 33.3 3 
 
In control group none of the obstetric variables were significant. 
Statistical significance was calculated using chi square test. 
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     Table 4.19: Association between level of constipation reduction 
among antenatal mothers in personal variables in control group 
Personal variables 
  
  
Constipation reduction score 
Total 
Chi 
square 
test 
Below 
DYHUDJH 
Above 
average(>1.87) 
frequency % frequency % 
Bowel habits Once in a 
day/two 
8 61.5 5 38.5 13 
F2=3.69 
p=0.15 
DF=2  
  Thrice a week 7 50.0 7 50.0 14 
  Once / twice a 
week 
 0  0.0 3 100.0 3 
Fluid intake >1500ml 3 42.9 4 57.1 7 F2=2.29 
p=0.31 
DF=2  
  <2000ml 8 66.7 4 33.3 12 
  >2000ml 4 36.4 7 63.6 11 
Dietary pattern Vegetarian 3 60.0 2 40.0 5 
F2=0.34 
p=0.84 
DF=2  
  Non 
Vegetarian 
3 42.9 4 57.1 7 
  Mixed 9 50.0 9 50.0 18 
Daily activities Regular 
walking 
2 33.3 4 66.7 6 
F2=0.84 
p=0.64 
DF=2   
  Once in  a 
while 
5 55.6 4 44.4 9 
  Not at all 8 53.3% 7 46.7 15 
Knowledge of 
health benefits 
of honey 
Yes 
11 55.0 9 45.0 20 
F2=0.60 
p=0.43 
DF=2  
  No 4 40.0 6 60.0 10 
Relief 
measures 
Home 
remedies 
7 41.2 10 58.8 17 F2=1.64 
p=0.44 
DF=2  
  Medical help 3 75.0 1 25.0 4 
  None 5 55.6 4 44.4 9 
 
In control group none of the personal variables were significant. 
Statistical significance was calculated using chi square test. 
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                               CHAPTER - V 
SUMMARY OF THE RESULTS 
This chapter deals with the summary of the results of the data analyzed 
based on the objectives of the study. The main aim of the study is to determine 
the effectiveness of honey on constipation among antenatal mothers in third 
trimester admitted in Institute of Obstetrics and Gynaecology and Govt hospital 
IRUZRPHQDQGFKLOGUHQ&KHQQDL´ 
 
The major findings of the study among antenatal mothers with 
constipation 
Based on demographic variables  
 Among experimental group majority of the mothers came under the 
age group of 20-25 years (46.7%) and in control group majority of 
them came under the age group of 26-30 years (53.3%). 
 Considering the educational status in experimental group majority, 
14 (46.7%) belonged to secondary education and in control group, 
10(33.3%) belonged to primary education. 
 Regarding occupational status both in experimental group 26(86.6%) 
and in control group, 24(80%) belonged to homemaker. 
 Regarding income of the experimental group 14(46.7%) under the 
Rs.5000-10000/- per month and in control group 15 (50%) under the 
Rs.>5000/- per month.  
 Regarding religion majority of the mothers in experimental group 
26(86.7%) and control group 21(70%) were Hindus. 
 Majority of the mothers in both experimental 11(36.7%) and control 
group, 13(43.3%) were rural population. 
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 Considering the type of family in experimental group, 20 (66.7%) 
belonged to joint family and in control group both nuclear families 
and joint families (50%) participated in this study. 
 
Based on obstetric and personal variables  
 Among experimental group, regarding the gravida of the mothers majority 
17 (56.7%) were multi gravida and in control group majority 18(60.0%) 
were primi gravida.  
 Regarding gestational age among experimental group, majority 13(43.3%) 
were between 37-40 weeks and in control group majority 12(40%) were 
between 32-36 weeks.  
 Among experimental group and control group, 27(90%) of mothers took 
iron tablets regularly during pregnancy.  
 In experimental group, regarding bowel habits of the mothers, majority 
18(60.0%) had bowel habits of once in a day/two and in control group, 
14(46.7%) of mothers had bowel habits of thrice in a week.  
 Considering the fluid intake in experimental group 19(63.3%) were 
>2000ml and among control group 15(50%) were >2000ml per day.  
 Regarding dietary pattern among experimental group majority 24(80%) of 
the mothers and in control group, 18(60%) were mixed diet.  
 Regarding the daily activities in both experimental and control group (15) 
50% of mothers not at all doing any exercises.  
 Among experimental group majority of the mother (18) 60% and in control 
group 20(66.7%) had knowledge about health benefits of honey.  
 Regarding relieving measures for constipation both experimental group (19) 
63.3%   and control group (17) 56.75% took home remedies. 
 
 
 
62 
 
Level of constipation  
 Considering pretest among experimental group majority of mothers 90% 
had minimal to moderate level of constipation, 10% had none to 
minimal constipation.  
 In pre-test among control group, 40.0% of the antenatal mothers were 
having none to minimal score, 60.0% of them had minimal to moderate 
score.  
 In post-test, among experimental group, 83.3% of antenatal mothers had 
none to minimal score, 16.7% of them had minimal to moderate score.  
 In post-test among control group, 13.3% of the antenatal mothers had 
none to minimal score, 86.7% of them had minimal to moderate score. 
 In pretest among experimental group, constipation score was 34.6% and 
in post-test 12.1%. 
 In pretest among control group, constipation score 35.8 % and in post-
test 30.3%.  
Comparison of pre-test and post-test among experimental and 
control group 
 Considering experimental group, in pre-test mean constipation score 
11.07 and in post-test score was 3.87. Difference is 7.20 score.  
Difference between pre-test and post-test score was analyzed using 
Student paired t-test. The difference between pre-test and post-test, 
t=14.79 p value=0.001 and it is statistically significant. 
 Considering control group, pre-test mean constipation score was 11.47 
and post-test score was 9.60 score and difference was 1.87 score.  The 
difference between pre-test and post-test score is small and it is not 
statistically significant.  
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Effectiveness of honey on constipation 
 In experimental group, mean difference between pre-test and post-test 
constipation score was 7.20 and percentage difference of constipation 
22.5% (95% CI 20.5%±24.5%). This shows the effectiveness of honey in 
relieving constipation.  
 Among control group mothers, mean difference between pre-test and post-
test constipation score was 1.87 and percentage difference of constipation 
5.8% (95% CI 1.1% ±10.5%). H1: There is significant difference in level of 
constipation among experimental and control group. Hence H1 is accepted. 
 
Association with selected demographic variables 
 
 Younger age (20-25) years p=0.01, more educated p=0.05 and joint 
family mothers p=0.02 are benefitted more than others. Statistical 
significance was calculated using chi square test. 
 Once in a day bowel habits, p=0.05 regular walking mothers p=0.04 
benefitted more than others. Statistical significance was calculated using 
chi square test.   
 There was significant association between level of constipation 
reduction with selected demographic and personal variables among the 
antenatal mothers in third trimester.  
 H2:  There is significant association between the level of constipation 
and the selected demographic variables. Hence H2 is accepted. 
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CHAPTER ± VI 
DISCUSSION 
This chapter deals with the discussion based on the objectives of the study. The 
main aim of the study is to determine the effectiveness of honey on constipation 
among antenatal mothers in third trimester admitted in Institute of Obstetrics and 
*\QDHFRORJ\DQG*RYWKRVSLWDOIRUZRPHQDQGFKLOGUHQ&KHQQDL´ 
 
Findings based on objectives 
 
x The first objective of the study was to assess the level of constipation 
among antenatal mothers in third trimester in both experimental and 
control group. 
 
In this study, in pre-test among experimental group majority of the mothers 
(90%) had minimal to moderate constipation, 10% had none to minimal constipation. 
In pre-test, total constipation score was 34.6%. 
In this study, in pre-test among control group mothers (13.3%) had none to 
minimal, majority of the mothers (86.7%) had minimal to moderate score .In control 
group total constipation score was 35.8%. 
The findings consistent with the study findings of Derbyshire et al. (2014) 
conducted two prospective cohort studies in Alaska were found with moderate study 
quality. The study estimates that the prevalence of constipation within the sample 
population was greatest in the first and second trimesters, 35% (95% CI 23-47%) and 
39% (95% CI 26-52%) respectively and in the third trimester, 21% (95% CI 10-32%). 
The mean prevalence rate of constipation during pregnancy of this study was 32%. 
Magan Trottier, MSc, Aida Erebara, MD, and Pina Bozzo8 et al. (2001) 
conducted a study on treating constipation in pregnancy. It has been estimated that 
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approximately 11% to 38% of pregnant women experience constipation, which is 
generally described as infrequent bowel movements or difficult evacuation. 
Vazquez J19. (2010) conducted a study on constipation, haemorrhoids, and 
heartburn in pregnancy in Los Angeles. They reported constipation in pregnant 
women varies between 11% and 38%. 
 
x The second objective of the study was to compare the level of constipation 
among antenatal mothers in third trimester in pre-test and post-test 
among experimental and control group. 
 
In experimental group, among pre-test women, the mean constipation score was 
11.07 and in post-test, they had 3.87 score and difference was 7.20 score.  The 
difference between pre-test and post-test score was large and it is statistically 
significant. Difference between pre-test and post-test score was analyzed using 
student paired t-test. t=14.79 p=0.001. 
In control group, among pre-test women, the mean constipation score was 11.47 
and in post-test, they had 9.60 score. The difference was 1.87 score.  The difference 
between pre-test and post-test score was small. Difference between pre-test and post-
test score was analyzed using student paired t-test.  It is not statistically significant. 
The findings consistent with the study findings of Huang Ali Jing38 et al. (2012), 
conducted an experimental study to determine the impact of (honey 10 ml) 2times a 
day for constipation. The incidence of constipation and degree of constipation of two 
groups were compared. The incidence of constipation in the experimental group was 
25%, in control group was 61.29%. The study concluded that administration of honey 
is effective in management of constipation. 
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x The third objective was to evaluate the effectiveness of honey on 
constipation among antenatal mothers in third trimester in experimental 
group. 
 
 In this study, in experimental group, mean difference between pre-test and post-
test constipation score was 7.20 and percentage difference of constipation 22.5% 
(95% CI 20.5%±24.5%). This shows the effectiveness of honey in relieving 
constipation.  
 In this study, among control group mothers, mean difference between pre-test and 
post-test constipation score was 1.87 and percentage difference of constipation 
5.8% (95% CI 1.1% ±10.5%). H1: There is significant difference in level of 
constipation among experimental and control group. Hence H1 is accepted. 
 
The findings nearly consistent with the study findings of Erejuva39 et al. 
(2012) conducted a quasi experimental study to assess the efficacy of honey with 
lemon juice in the treatment of constipation in China. The incidence of constipation 
was lower in the intervention group than that in the control group (p<0.05). The study 
concluded that honey was effective in treating constipation.  
 
 
x The fourth objective was to find the association of level of constipation 
with selected demographic variables among the antenatal mothers in third 
trimester. 
 
In this study, there was significant association between younger age (20-25) 
years, F2 p value=0.0, more educated (graduates) F2=8.73. p=0.05 and joint family 
mothers, F2=5.40.p value=0.02 were benefitted more than others. Statistical 
significance was calculated using chi square test. There was significant association 
between levels of constipation reduction score with selected demographic variables 
among the antenatal mothers in third trimester. 
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 There was significant association between level of constipation reduction with 
selected personal variables among the antenatal mothers in third trimester. Once in a 
day/ two bowel habits, F2=6.60 p value=0.05, regular walking mothers F2=6.71, 
p value=0.04 were benefitted more than others. Statistical significance was 
calculated using chi square test. 
The findings consistent with the study findings Derbyshire 32et al and  
Bradley 14 et al. (2015) this systematic review aimed to identify the diagnostic criteria 
of constipation during pregnancy, its prevalence during the three trimesters, as well as 
the effects and efficacy of different interventions for its prevention or treatment. 
Regarding constipation treatment, during pregnancy abundant fluid intake and 
physical activity improve constipation. Light physical activity appears to promote 
regular bowel movements during pregnancy; therefore a sedentary lifestyle may 
likewise cause or exacerbate constipation. They found association between physical 
activity and constipation during pregnancy.  
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CHAPTER VII 
CONCLUSION AND RECOMMENDATION 
Constipation during pregnancy is a common problem. Nowadays only few 
effective interventions are published in preventing or treating constipation during 
pregnancy. The studies investigating the potential role of honey in the management of 
constipation are really effective. It is worth mentioning that honey administration 
improves health status. 
7.1 Implications 
The investigator had drawn the following implications from the study which is 
of vital concern in the field of nursing practice, nursing administration, nursing 
education and nursing research. 
I) Nursing practice 
1. Evidence based nursing care practices are in greater need to improve the 
quality of patient care. High quality and cost effective nursing care is only 
possible through research in the area of nursing profession.  
2. Nurse researchers regularly make modest attempts to generate or refine the 
nursing interventions.  
3. Nurses have the opportunity to lead the multidisciplinary team in 
XQGHUVWDQGLQJ WKH FOLHQW¶V SUREOHP+HDOWK FDUH SURYLGHU PD\ re-evaluate 
the traditional practices. 
II) Nursing administration 
1. With technological advancement and ever growing challenges of health 
care needs, the administrators have the responsibility to provide nurses with 
substantive information through educational opportunities.  
2. Nursing administrators or leaders should take interest in formulating 
principles and adapting the various modalities of non pharmacological 
management.  
3. Nursing administrators can derive policies on complementary and 
alternative therapies. 
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4. Nurse administrators may consider allocating resources for conducting 
various staff development programs and provide opportunity for the nurses 
to attend national and international conferences. 
III) Nursing education 
1. The results of the study emphasis the learners to utilize the knowledge, as a 
nurse educator we must strengthen the concept of non-pharmacological 
methods for treating health problems.  
2. Complementary and Alternative medicine has been included in the 
curriculum of nursing education. Integration of theory into practice is vital 
need and it is important in nursing education.  
3. Nursing students should be exposed to these areas and to learn regarding 
these types of interventions.  
IV) Nursing research 
1. The scope of nursing research is to strengthen the body of knowledge in 
nursing practices, education, and administration. The finding can be a 
baseline for further studies to improve the body of knowledge in nursing.  
2. The nurse researcher should motivate the clinical nurse to do further 
research studies on effectiveness of honey in various gastro intestinal 
problems.  
3. The nurse researcher should encourage clinical nurse to apply the research 
findings in their daily nursing care activities and can bring out new 
innovative procedures to prevent constipation during pregnancy and after 
delivery. 
4. The nurse researchers may conduct periodic review on research findings 
and disseminate the finding through conferences, seminars and publications 
in professional, national and international journals and also in the World 
Wide Web. 
7.2 Limitations 
x The study was done with small samples. 
x The study was done in limited study setting 
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7.3 Recommendation for further studies  
 The study can be replicated on larger samples in multi stage for better 
generalization 
 The similar study can be conducted in different settings, postnatal wards 
and post operative wards. 
 A study can be conducted to evaluate the cost effectiveness of the honey 
in terms of laxatives used. 
 To increase the efficacy of existing methods, combinational methods may be 
explored.  
 Novel and innovative therapies of complementary and alternative medicine can 
be recommended in future studies for treating constipation.  
Conclusion  
             Constipation during pregnancy is a common problem. Nowadays only few 
effective interventions are published in preventing or treating constipation during 
pregnancy. It is worth mentioning that honey consumption improves health status. 
Honey therapy for constipation is easy to implement, safe for pregnant women, non-
invasive, and low-cost. There is marked reduction of level of constipation among 
pregnant women.  
The study reveals that administration of honey for three days, majority of the 
women relieved from constipation. It may be recommended for home therapy, which 
is easily available and good for health in all ages. The excavated results supported the 
incorporation of complementary medicine to relieve constipation among antenatal 
mothers. Complementary and alternative medicine is expected to play a more 
important role in the future.  
 
 
 
a 
 
REFERENCES 
 
1. Fraser DM, Cooper MA. Text book for Midwife. 14th ed. New York : Churchill  
Livingstone; 2003. 
2. D.C.Dutta. Text book of Obstetrics.7th ed. Kolkata : New Central Book 
Agency;2011.p.43  
3. Reeder, Martin. Maternity Nursing.19th ed. New Delhi: Wolters Kluwer 
(India); 2014.  
4. Trottier M, Erebara A, Bozzo P. Treating constipation during pregnancy. 
Canadian Family Physician. 2012 Aug; 58:836-838.    
5. Rome foundation. Guidelines²Rome 3 diagnostic criteria for functional 
gastrointestinal disorders. J Gastro intestinal Liver Diseases. 2006 Sep; 
15(3):307±312. 
6. Longo S, Moore R., Canzoneri B, Robichaux A. Gastrointestinal Conditions 
during Pregnancy. Clinics in Colon and Rectal Surgery. 2010; 23(2):80-89.   
7. Tytgat G, Heading R, Muller-Lissner S, et. al. A contemporary understanding 
and management of reflux and constipation in the general population and 
pregnancy: Aliment Pharmacol Ther. 2003; 18(3):291±301.  
8. Trottier M, Erebara A, Bozzo P. Treating constipation during pregnancy. 
Canadian Family Physician. 2012 Aug; 58:836-838. 
9. Higgins J.P.T, Green S. Cochrane Handbook for Systematic Reviews of 
Interventions, Version 5.1.0 [Internet]. The Cochrane Collaboration; 2008.  
10. http://www.americanpregnancy.org/main/statistic.html.  
11. &XOOHQ * 2¶'RQRJKXH ' Constipation and pregnancy. Best Practice & 
Research Clinical Gastroenterology. 2007; 21(5):807±818.  
12. Stevenson L, Phillips F, O'sullivan K, Walton J. Wheat bran: its composition 
and benefits to health, a European perspective. International Journal of Food 
Sciences and Nutrition. 2012 Dec; 63(8):1001±1013.  
13. $UWDO52¶7RROH0*XLGHOLQHVRIWKH$PHULFDQFROOHJHRIREVWHWULFLDQVDQG 
 gynaecologists for exercise during pregnancy and the postpartum period 
 Br J Sports Med. 2003; 37:6±12.  
b 
 
14. Bradley C, Kennedy C, Turcea A, Rao S, Nygaard. I. et.al. Constipation in 
Pregnancy: Prevalence, symptoms, and risk factors. The American college of 
Obstetrics & Gynecolology  vol. 110(6): 1351±57 
15. Milliano I, Tabbers M, Post J, Benninga M. Is a multispecies probiotic mixture 
effectivein constipation during pregnancy? 'A pilot study'. Nutrition Journal. 
2012; 11(80):1-6. 
16. Chow J. Probiotics and prebiotics: a brief overview. J Ren Nutrition (2002)12: 
17. http://www.ishafoundation.org/blog/lifestyle/health-fitness/health-benefits-
honey-uses/ 
18. White JW. Composition of honey. In: Crane E, editor. Honey: Comprehensive 
Survey. London: Heinemann; 1979. pp. 157±192.  
19. Vazquez JC (2008) Constipation, Haemorrhoids and heartburn in pregnancy. 
BMJ Clinical Evidence 02: 14 
20. The Indian Society of Gastroenterology Task Force. Epidemiological and 
clinical profile of irritable bowel syndrome in India. 2008; 27(1): p.22-26.  
21. Tatnall, F M; Leigh, I M; Gibson, J R (1991) Assay of antiseptic agents in cell 
culture: conditions affecting cytotoxicity. Journal of Hospital Infection 17(4); 
287-296.  
22. http://ayurveda-foryou.com  
23. https://www.healthtap.com/user  
24. www.findhomeremedy.com/home-remedies-for-constipation 
25. Zumla A, Lulat A. Honey: A remedy rediscovered. J R Social Medicine. 1989; 
vol.82 384±385.  
26. Mr .Azhim Sanyal . Dabur honey ranked No:1 in purity. The Times of India. 
Chennai edition.2016 Jan . vol. 9(24); 1 
27. Dik VK, Siersema PD, Joseph A, et al. (2014) drugs for gastrointestinal 
disorders in pregnant women. 2014. Nat.clinic gastro practice. 2006.vol ;3 
 
 
 
 
c 
 
28. Yiannakou Y . Effectiveness of  prucalopride in constipation. Br J Obstet 
Gynaecol .2014, 93:245±249. 
29. Layer P, Stanghellini V. Constipation in the general population and pregnancy. 
Ailment Pharmacol Ther. 2014, 18:291±301. 
30. Chevalier P, Lamotte M. Billed costs, drug use, diagnoses, and procedures. 
Wiley online library. 
31. Derbyshire E, Davies J, Costarelli V et al (2006) Diet, physical inactivity and  
the prevalence of constipation throughout and after pregnancy. Maternal Child 
Nutrition 2(3): 127±34. 
32. Jewell DJ & Young G (2009) Interventions for treating constipation in 
pregnancy. Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: 
CD001142. 
33. Ponce J, Martinez B, Fernandez A et al (2008) Constipation during pregnancy: 
a longitudinal survey based on self reported symptoms and the Rome II criteria. 
British Journal of obstetrics and Gynaecology vol.20(1): 56±6 
34. Kathleen Marshall, Kate A. Thompson. (2007) International Journal of 
Obstetrics & Gynaecology , 
35. H. Jorien van Brummen. Constipation and diarrhoea in pregnancy. 
Gastroenterol Clin North Am , 2008.27:197±211 
36. AS Anderson - BJOG: An International Journal of Obstetrics & gynaecoly 
Wiley Online Library 
37. Neri I, Blasi I, Castro P et.al. Constipation during pregnancy: Journal of 
0LGZLIHU\	:RPHQ¶VHealth. 2004 Jul/Aug; 49(4):355-358. 
38. Levy N, LembergE, Sharf M et al. prevalence of constipation in pregnancy. 
The Cochrane Collaboration; 2008. 
39. Erejuwa OO, Sulaiman SA, Wahab MS: Effect of honey on Gut health. 
Molecules 2012, 17:1900±1915. 
40. Doreen mc clurg et al. (2011) The role of honey in the management 
constipation. J gut care 2011,8:415±418. 
41.  Lars Lindholm et al. Effect of honey in gatro intestinal disorder. Molecules 
2009, 17:1900±1915. 
d 
 
42. Levy N, LembergE, Sharf M et al. (2002) The Honey prescription the amazing 
power of honey as medicine: Healing arts press;2010. 
43. Jung HM et.al. (2004) Contribution of honey in nutrition and human health: 
Mediterranean J Nutr Metab 2004, 3:15±23 
44. Bernadette Baca, Health Physicist.Division of Reactor Safety, international 
honey research organisation. Strength Conditioning J 2002, 24:50±51. 
45. Wang et al. Antimutagenic properties of honey.  J Agric Food Chem.2012, 
50:3050±3055. 
46. Tahereh Eteraf-Oskouei and Moslem Najafi. (2008) The role of honey in the 
management of wounds. J wound care.2008. 8:415±418. 
47.  Pieper, Barbara. (2007) The antibacterial activity of honey. Bee World 1992, 
73:59±75. 
48. Bansal V, Medhi B, Pandhi P. Clinical study on the topical use of honey in 
ocular diseases. Bull Islam med.2005. 2(5):422±425. 
49. Lynne M. Bang, Catherine Buntting.  Antibacterial activity of hydrogen 
peroxide in honey. Healing press arts. 2003.41(08)200-210. 
50. Al-Waili NS: Natural honey lowers plasma glucose, C-reactive protein, and 
blood lipids in healthy, Comparison with dextrose and sucrose. J Med Food 
2004, 7:100±107 
51. Selwyn AP, Braunwald E.  Antioxidants in honey. Br Med J.2001. 290 
1866±1867 
52. Al-Jabri AA.(2001)  patients with type-2diabetes mellitus. Eur. J.med. Res 
2003.8.295-303. 
53. Wesley R. Nursing Theories and Models, 2nd ed. Pennysilvania: Springhouse 
Publication; 2005. 
54. Polit and Hungler. Text book of Nursing Research, Sixth edition, Philadelphia, 
J.B.Lippincott Company. 1999 
55. Broussard B.S. The constipation assessment scale for pregnancy. JOGNN. 
1998;vol 27: 297-301. 
 
 
e 
 
JOURNALS 
1. Alvarez-Suarez JM, Tulipani S, Romandini S, Bertoli E, Battino M. 
Contribution of honey in nutrition and human health: a review. Mediterr J Nutr 
Metab. 2010;3:15±23. 
2. Avanagh,D;  Beazley,J;  Ostapowi CF1970) A new approach t o  honey 
therapy, British Commonwealth 77(11): 1037-1040. 
3. Bloomfield. E (1976) Old remedies. Journal  of the Royal College of General 
Practitioners vol.26.576. 
4. Bradley CS, Kennedy CM, Turcea AM et .al. (2007) Constipation in 
pregnancy: Prevalence, symptoms, and risk factors. The American college of 
Obstetrics & Gynecolology  vol. 110(6): 1351±57. 
5. Brooks,FP ( 1985)  The pathophysiology of  Digestive Diseases and Sciences 
30(1 1): 15-29 
6. Chow J. Probiotics and prebiotics: a brief overview. J Ren Nutrition 
(2002)12:11-102. 
7. Derbyshire E, Davies J, Costarelli V et al (2006) Diet, physical inactivity and  
the prevalence of constipation throughout and after pregnancy. Maternal Child 
Nutrition 2(3): 127±34. 
8. Eugene S. Bonapace, Robert S. Fisher(1998)constipation and diarrhoea in 
pregnancy, Gastroenterology Clinics of North America, Volume 27, Issue 1, 
Pages 197-211. 
9. Jewell DJ & Young G (2009) Interventions for treating constipation in 
pregnancy. Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: 
CD001142. 
10. .Li , Atm M;  Al- Swayeh,O.A ( 1996)  The role of nitric oxide in gastric 
protection by honey. Saudi Medical Journal vol 17: 301-306. 
11. Marshall, D Totterdal, V  McConnell, constipation during pregnancy. 
Malaysian Journal of Medical Sciences.Jan2007, Vol. 14 Issue 1, p118-119.    
12. .Mcinerney, R J F (1990) Honey - a remedy rediscovered. Journal of the Royal 
Society of Medicine .vol 83: 127. 92. 
f 
 
13. .Meyer LC, Peacock JL, Bland JM et al (1994) Symptoms and health problems 
in pregnancy: their association with social factors. Paediatr Perinatal 
Epidemiol vol.8: 145±55. 
14. Molan, P C (1999) Why honey is effective as a medicine.   Bee World 80(2):   
80-92. 
15. Ponce J, Martinez B, Fernandez A et al (2008) Constipation during pregnancy: 
a longitudinal survey based on self reported symptoms and the Rome II criteria. 
British Journal of obstetrics and Gynaecology vol.20(1): 56±6 
16. .Ramamoorthy, U; Thomas Joseph, K(1993) Influence of honey on 
biochemical and biophysical parameters. Journal of Clinical Biochemistry and 
Nutrition, vol:14:91-99.  
17. .S A; Mutawau, I; Wadi, M (1988) Studies on Sudanese bee honey: laboratory 
and clinical evaluation. International Journal of Crude Drug Research 26(3): 
161-168. 
18. Vazquez JC (2008) Constipation, Haemorrhoids and heartburn in pregnancy. 
BMJ Clinical Evidence 02: 14. 
 
 
 
 
 
 
 
 
 
 
g 
 
NET SOURCE  
i. www.pubmed.com 
ii. www.ncbi.nlm.nih.gov 
iii. www.wikipedia.org 
iv. googlescholar.blogspot.com 
v. www.sciencedirect.com 
vi. www.medicinenet.com 
vii. www.webcrawler.com 
viii. www.natural-homeremedies.com 
ix. www.bee-hexagon.net 
x. www.ijbs.com 
xi. www.activebeat.com 
xii. www.findhomeremedy.com 
xiii. www.ishafoundation.org 
xiv.   www.healthtap.com 
xv. www.chinaview.cn 
xvi.   www.cochrane-handbook.org  
xvii.   ayurveda-foryou.com 
xviii.   www.jaypeejournals.com 
xix.  www. proquest.com 
                                   
 
 
 
 
 
 
 
 
i 
 
ii 
 
iii 
 
iv 
 
v 
 
 
20-25    ( )   
                                                                   
26-30    ( )                                                                     
 31-35    ( )                                                                      
36-40    ( )       
 
 
5000     ( )
                                   
 5001 -10000   ( )                                                       
               10,000    ( ) 
vi 
 
                                                                                                              
            
 
 
vii 
 
 
 
viii 
 
 
 
   
 
 
 
     
 
     
 
     
 
     
 
     
      
 
     
 
 
 
 
 
 
 
 
ix 
 
Appendix 
SECTION- A 
DEMOGRAPHIC VARIABLES 
Sample Number: 
1. Age in years  
a) 20-25     ( )                                                                     
b) 26-30      ( )                                                                    
c) 31-35     ( )                                                                     
d) 36-40     ( )         
2. Educational status   
a) No formal education   ( )  
b) Primary education   ( )                                               
c) Secondary education   ( )                                          
d) Graduate & post graduate  ( )     
3. Occupation  
a) Home maker    ( )                                                         
b) Self employed    ( )                                                       
c) Private employee   ( )                                                 
d) Government employee           ( )                      
4. Monthly income of the family (in Rupees) 
a)  >5000                              ( )                                                      
b) 5001 -10000    ( )                                                
c)  >10,000     ( )            
5. Religion  
d) Hindu     ( )                                                                     
e) Muslim    ( )                                                                   
f) Christian     ( )                                                               
g) Others     ( )                                                                                      
6. Residence                 
a) Rural     ( )                                                                     
b) Sub-urban    ( )      
c) Urban     ( ) 
 
    
x 
 
7. Type of family  
a) Nuclear family   ( )                                                     
b) Joint family    ( )                                                          
c) Extended family  ( )                                                   
 
SECTION -B 
OBSTETRICAL VARIABLES  
1. Gravida 
a) Primi           ( )                                      
b) Multi     ( )                                                                      
2. Gestational age  
a) 27-31 weeks     ( )                                                                         
b) 32-36 weeks    ( )                                                        
c) 37-40weeks    ( )                                                         
3. Consumption  of iron tablets during pregnancy 
a) Regular    ( )                                     
b) Irregular    ( )                                                          
    
                       
SECTION -C 
PERSONAL VARIABLEs 
1. Bowel habits  
a) Once in a day/two   ( )                                              
b) Thrice a week     ( )                                                     
c) Once / twice a week   ( )                                          
2. Fluid intake per day  
a) >1500ml       ( )                                                  
b) <2000ml    ( )                                                     
c)  >2000ml                 ( )           
 
 
xi 
 
 
       3.  Dietary pattern  
a) Vegetarian     ( )                                                  
b) Non Vegetarian     ( )  
c) Mixed                   ( )                                                          
4. Daily activities  
a) Regular walking   ( )    
b) Once in  a while   ( )    
c) Not at all      ( )       
       5. Knowledge about health benefits of honey  
Yes        ( ) 
No      ( )    
      6.  Relieving   measures       
a) Home remedies    ( )                                                
b) Medical help    ( )                                                      
c) None       ( )          
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SECTION -D 
The Constipation Assessment Scale for Pregnancy is an adaptation of 
the Constipation Assessment Scale of McMillan and Williams 
(Broussard, 1998), differing essentially in the use of a 5-point rather 
than a 3-point rating scale for each of the constipation characteristics. 
The change was apparently made in the interest of producing interval 
level data that would allow parametric statistical testing. Trait validity, 
internal consistency and test-retest scores are, not surprisingly, similar 
to those of the McMillan and Williams scale. Future studies designed to 
identify potential therapeutic interventions for constipation during 
pregnancy could use the CAS for pregnancy as a measurement 
instrument. 
 
 
 
 
Table 5.2 The Constipation Assessment Scale for Pregnancy  
Abdominal distension or bloating 
Change in amount of gas passed 
rectally   
Less frequent bowel movements 
Oozing liquid stool 
Rectal fullness or pressure 
Rectal pain with bowel movement 
Small volume of stool 
Unable to pass stool  
None 
None  
None 
None 
None 
None 
None 
None  
Mild  
Mild  
Mild 
Mild 
Mild 
Mild 
Mild 
Mild  
Moderate  
Moderate  
Moderate 
Moderate 
Moderate 
Moderate 
Moderate 
Moderate  
Severe  
Severe  
Severe 
Severe 
Severe 
Severe 
Severe 
Severe  
Very Severe 
Very Severe  
Very Severe 
Very Severe 
Very Severe 
Very Severe 
Very Severe 
Very Severe  
(Broussard, 1998
 
 Modified the score for pregnant women by using 5- point scale, scored 0-4, None-0, Mild-1, 
Moderate-2, Severe-3, Very Severe-4, providing total score range of 0-32 
 (0-8= None to Minimal; 9-17= Minimal to Moderate; >25 = Moderate to Severe) 
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CODING SHEETS 
Control group-pre-test (Demographic variables) 
  
  
Sample 
 Age in 
years  
Educational 
status Occupation 
Monthly 
income  Religion  Residence 
Type of 
family 
1 B D A C A C B 
2 A D A B A C A 
3 B B A B A A B 
4 A C A B A B A 
5 A D A C A B A 
6 A C A B B A A 
7 B B A B A A B 
8 B A C A B B A 
9 B A B A A B A 
10 B A B A A A A 
11 A B A A A A B 
12 B C C B A B B 
13 C C A A C B A 
14 B D A B A C B 
15 B B A A A A B 
16 C A A A A A B 
17 A C A A C B A 
18 B C A A C A B 
19 B C A B A B B 
20 C D C A A C A 
21 B B A A A A B 
22 A A A A A A B 
23 B C A B C B A 
24 B B A A B B B 
25 C B A A B B B 
26 C A A A A A B 
27 A D C B A C A 
28 B B A A B B B 
29 A A A A A A B 
30 B B A A A A B 
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Control group-pre-test (obstetric variables) 
 
Sample 
No Gravida 
Gestational 
age 
Consumption of iron 
tablets  
1 A B a 
2 A B A 
3 A C A 
4 A C A 
5 A A A 
6 A C A 
7 B B A 
8 A B B 
9 B A A 
10 B A A 
11 A B A 
12 B B A 
13 A B A 
14 B C A 
15 B C B 
16 B B A 
17 A B A 
18 A B A 
19 A A A 
20 A B A 
21 A A A 
22 A A A 
23 B C A 
24 A A A 
25 B C B 
26 B B A 
27 A C A 
28 A A A 
29 A A A 
30 A C A 
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Control group-pre-test (Personal variables) 
 
Sample 
No 
Bowel 
habits  
Fluid 
intake  
Dietary 
pattern 
Daily 
activities 
Knowledge of 
health benefits 
of honey 
Relief 
measures 
1 A C A A A A 
2 A C C C A C 
3 A C C C A C 
4 A C C A B A 
5 A C C C A C 
6 B A B B A A 
7 B C B A A A 
8 B A C C A B 
9 C C C C B A 
10 C A C B A C 
11 B B B B B A 
12 B B C A A A 
13 A C C B B C 
14 A C C B A B 
15 A B B B A A 
16 B B C C A C 
17 B C B B B A 
18 B C C C B A 
19 A B A A A A 
20 A C C B B A 
21 B A C C A A 
22 B B B C B C 
23 A B C C A A 
24 B B B C A A 
25 B A C C A A 
26 B B C C A C 
27 B C A B A B 
28 A C C A A B 
29 A A A C B C 
30 A A A C B A 
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Experimental group-pre-test (Demographic variables) 
 
Sample 
 Age in 
years  
Educational 
status Occupation 
Monthly 
income  Religion  Residence 
Type of 
family 
1 A D A B A A A 
2 A C A B A A A 
3 B C A B A B A 
4 B C A A A C A 
5 A C A B A A A 
6 B C A B A B A 
7 B C A C A C A 
8 A B A C B B A 
9 B D A C C A B 
10 A C A B A B B 
11 A C A B A A A 
12 D B A B A A B 
13 B A A A A A A 
14 B D A C A B A 
15 A C A B A C B 
16 A B A B A B B 
17 A D A A A C B 
18 A C A C A C B 
19 A C A B A C A 
20 B B A B A A A 
21 A C A B A C A 
22 A C A C A C B 
23 A B A A B C A 
24 B D A A A A A 
25 B C A A A B B 
26 B D A A A A A 
27 A C A B C A B 
28 B C A A A B A 
29 B D A A A C A 
30 B B A A A B A 
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 Experimental group-pre-test (Obstetric variables) 
 
 
Sample No Gravida 
Gestational 
age 
Consumption 
of iron 
tablets 
1 A B B 
2 B C A 
3 B C B 
4 B A A 
5 B B B 
6 A A A 
7 B B A 
8 B B A 
9 B C A 
10 A B A 
11 A B A 
12 B C A 
13 B B A 
14 A B A 
15 A B A 
16 B A A 
17 A C A 
18 B C A 
19 B C A 
20 B C A 
21 B C A 
22 B A A 
23 B B A 
24 A C A 
25 A C A 
26 A C A 
27 A A A 
28 A A A 
29 A A A 
30 B C A 
 
 
 
 
xx 
 
 
 Experimental group-pre-test (Personal variables) 
 
 
Sample No 
Bowel 
habits  
Fluid 
intake  
Dietary 
pattern 
Daily 
activities 
Knowledge 
of health 
benefits of 
honey 
Relief 
measures 
1 B A C C B A 
2 B B C C A C 
3 A C C C B C 
4 A C A C A A 
5 A B C C A A 
6 A C C C B C 
7 B C C C A C 
8 A A C C A A 
9 B C C B A A 
10 A C C C B A 
11 B B C C B A 
12 B B B B A C 
13 A B C C A C 
14 A C C A A A 
15 A C C B A C 
16 B B C C B A 
17 A C C B A A 
18 A C C A A A 
19 A C C C A A 
20 A B C C A C 
21 B B C C B A 
22 B C C A A A 
23 A C C B A C 
24 A C C A A A 
25 B B B B B C 
26 A C C A A A 
27 A C C A A A 
28 A C C A B A 
29 A C C A A C 
30 A C C A B A 
 
 
 
xxi 
 
 
Constipation score based on constipation assessment scale 
Experimental group                             Control group 
Sample Pre-test Post -test 
1 9 6 
2 9 5 
3 8 4 
4 15 9 
5 12 9 
6 12 9 
7 10 5 
8 11 5 
9 12 9 
10 14 9 
11 8 4 
12 8 4 
13 13 9 
14 12 9 
15 9 5 
16 12 8 
17 10 5 
18 13 9 
19 13 9 
20 10 6 
21 12 9 
22 14 8 
23 8 4 
24 10 6 
25 9 5 
26 9 4 
27 9 4 
28 9 4 
29 12 9 
30 9 5 
 
Sample Pre-test Post- test 
  1 12 3 
2 10 2 
3 17 9 
4 11 2 
5 11 2 
6 9 2 
7 16 9 
8 10 2 
9 12 2 
10 9 0 
11 9 1 
12 16 9 
13 8 0 
14 9 0 
15 10 2 
16 12 3 
17 9 2 
18 12 2 
19 16 9 
20 9 0 
21 10 1 
22 17 9 
23 8 0 
24 13 2 
25 10 1 
26 10 0 
27 8 0 
28 18 9 
29 9 0 
30 9 0 
xx
ii 
 Pr
e 
- a
ss
es
sm
en
t e
xp
er
im
en
ta
l g
ro
up
 
SI
 
N O
 
IT
EM
S 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
1 
1 
2 
1 
3 
1 
2 
1 
2 
2 
2 
1 
0 
2 
1 
1 
0 
2 
0 
1 
1 
1 
1 
3 
0 
2 
2 
1 
1 
2 
1 
0 
2 
2 
0 
0 
0 
1 
0 
0 
1 
1 
1 
0 
0 
0 
0 
0 
1 
2 
0 
1 
1 
1 
1 
2 
1 
0 
0 
1 
0 
1 
0 
0 
3 
3 
2 
1 
3 
1 
1 
1 
2 
0 
1 
2 
2 
2 
1 
0 
2 
1 
2 
2 
2 
2 
2 
2 
1 
2 
1 
2 
1 
2 
2 
2 
4 
4 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
5 
5 
3 
3 
3 
3 
3 
3 
3 
3 
3 
2 
2 
3 
2 
3 
2 
3 
3 
2 
3 
2 
2 
3 
2 
3 
2 
2 
2 
4 
2 
2 
6 
6 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
2 
1 
0 
0 
2 
0 
3 
0 
0 
0 
1 
0 
0 
7 
7 
3 
3 
3 
2 
3 
2 
3 
2 
3 
2 
3 
4 
2 
2 
3 
2 
2 
2 
3 
1 
2 
3 
2 
0 
3 
2 
2 
3 
2 
3 
8 
8 
2 
2 
3 
3 
2 
2 
3 
2 
2 
2 
2 
3 
2 
3 
2 
2 
2 
2 
3 
2 
2 
2 
2 
3 
2 
2 
2 
3 
2 
2 
To
ta
l 
12
 
10
 
15
 
11
 
11
 
9 
15
 
10
 
12
 
9 
9 
15
 
8 
9 
10
 
12
 
9 
12
 
14
 
9 
10
 
17
 
8 
13
 
10
 
10
 
8 
16
 
9 
9 
        
xx
iii
 
 Po
st
 a
ss
es
sm
en
t e
xp
er
im
en
ta
l g
ro
up
 
SI
 
N
O
 
IT
EM
S 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
1 
1 
1 
0 
2 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
2 
0 
0 
0 
0 
0 
0 
0 
0 
2 
2 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
3 
3 
0 
0 
2 
0 
1 
1 
2 
1 
1 
1 
0 
2 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
4 
4 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
5 
5 
1 
1 
2 
1 
1 
0 
2 
0 
0 
0 
0 
2 
0 
0 
1 
1 
0 
1 
2 
0 
1 
2 
0 
1 
1 
0 
0 
3 
0 
0 
6 
6 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
7 
7 
2 
1 
2 
1 
2 
1 
2 
1 
0 
0 
0 
3 
0 
0 
0 
1 
1 
1 
2 
0 
0 
3 
0 
0 
0 
0 
0 
3 
0 
0 
8 
8 
1 
0 
1 
0 
0 
0 
2 
0 
0 
0 
0 
2 
0 
0 
1 
1 
0 
1 
2 
0 
0 
2 
0 
0 
0 
0 
0 
3 
0 
0 
To
ta
l 
3 
2 
9 
2 
4 
2 
9 
2 
2 
1 
0 
9 
0 
0 
2 
3 
1 
3 
6 
0 
1 
9 
0 
2 
1 
0 
0 
9 
0 
0 
         
xx
iv
 
 Pr
e 
as
se
ss
m
en
t c
on
tr
ol
 g
ro
up
 
SI
 
N
O
 
IT
EM
S 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
1 
1 
1 
1 
1 
2 
1 
1 
1 
1 
1 
2 
1 
0 
2 
1 
1 
1 
1 
2 
2 
1 
1 
0 
0 
1 
0 
0 
0 
0 
1 
0 
2 
2 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
3 
3 
1 
1 
0 
3 
2 
1 
1 
1 
2 
2 
1 
0 
1 
1 
0 
1 
1 
1 
1 
1 
2 
2 
1 
1 
2 
1 
0 
1 
1 
0 
4 
4 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
5 
5 
2 
2 
3 
4 
3 
4 
3 
3 
3 
3 
2 
2 
4 
4 
3 
3 
2 
4 
3 
2 
3 
4 
2 
3 
2 
3 
3 
3 
4 
4 
6 
6 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
7 
7 
2 
3 
2 
3 
3 
3 
3 
3 
3 
3 
2 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
2 
2 
2 
2 
3 
3 
3 
3 
8 
8 
3 
2 
2 
3 
3 
3 
2 
2 
3 
3 
3 
3 
3 
3 
2 
3 
3 
3 
4 
3 
3 
4 
3 
3 
3 
3 
3 
2 
3 
2 
To
ta
l 
9 
9 
8 
15
 
12
 
12
 
10
 
11
 
12
 
14
 
8 
8 
13
 
12
 
9 
12
 
10
 
13
 
13
 
10
 
12
 
14
 
8 
10
 
9 
9 
9 
9 
12
 
9 
         
xx
v 
 Po
st
 a
ss
es
sm
en
t c
on
tr
ol
 g
ro
up
 
 S
I N
O
 
IT
EM
S 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
1 
1 
0 
0 
0 
0 
0 
0 
1 
0 
1 
1 
0 
0 
0 
0 
0 
0 
0 
1 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
2 
2 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
3 
3 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
1 
1 
1 
0 
0 
0 
0 
0 
1 
0 
0 
0 
1 
0 
4 
4 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
5 
5 
2 
1 
2 
3 
3 
3 
1 
2 
3 
2 
1 
0 
3 
3 
2 
3 
2 
3 
2 
2 
3 
2 
2 
2 
2 
2 
1 
2 
2 
2 
6 
6 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
7 
7 
2 
2 
1 
3 
3 
3 
2 
2 
2 
3 
1 
2 
3 
3 
2 
3 
1 
2 
2 
2 
3 
3 
1 
2 
1 
1 
1 
1 
3 
1 
8 
8 
2 
2 
1 
3 
3 
3 
1 
1 
2 
3 
2 
2 
3 
3 
1 
2 
1 
2 
2 
2 
3 
3 
1 
2 
1 
1 
2 
1 
3 
2 
To
ta
l 
6 
5 
4 
9 
9 
9 
5 
5 
9 
9 
4 
4 
9 
9 
5 
8 
5 
9 
8 
6 
9 
8 
4 
6 
5 
4 
4 
4 
9 
5 
  
xxvi 
 
 
 
 
 
 
 
